Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_AF,FGF5,Fibroblast growth factor 5,Inverse variance weighted,36,1.12 [1.09-1.16],1.75546582943659e-12,cis
Chapter IX Diseases of the circulatory system,I9_AF,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,21,1.06 [1.04-1.09],1.70009936887619e-07,cis
Chapter IX Diseases of the circulatory system,I9_AF,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,5,1.1 [1.06-1.15],2.96399162877655e-06,cis
Chapter IX Diseases of the circulatory system,I9_AF,F10,Coagulation factor X,Inverse variance weighted,9,1.08 [1.04-1.11],4.90616308713515e-06,cis
Chapter IX Diseases of the circulatory system,I9_AF,LMOD1,Leiomodin-1,Inverse variance weighted,5,0.69 [0.59-0.81],9.38797490078074e-06,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,0.86 [0.8-0.93],3.85868204716196e-05,cis
Chapter IX Diseases of the circulatory system,I9_AF,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.69 [0.58-0.83],6.10348849502977e-05,cis
Chapter IX Diseases of the circulatory system,I9_AF,NT5E,5'-nucleotidase,Inverse variance weighted,45,0.95 [0.93-0.98],0.000522108721996475,cis
Chapter IX Diseases of the circulatory system,I9_AF,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,2,0.69 [0.56-0.86],0.000640905197575166,cis
Chapter IX Diseases of the circulatory system,I9_AF,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.31 [1.12-1.53],0.000816080089955002,cis
Chapter IX Diseases of the circulatory system,I9_AF,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,22,0.93 [0.89-0.97],0.000976157859854379,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.89 [0.83-0.96],0.00153480509925468,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,2.07 [1.32-3.26],0.00157746582446619,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,21,0.94 [0.91-0.98],0.00162073276410543,cis
Chapter IX Diseases of the circulatory system,I9_AF,LCAT,Phosphatidylcholine-sterol acyltransferase,Wald ratio,1,1.33 [1.11-1.59],0.00188077583202879,cis
Chapter IX Diseases of the circulatory system,I9_AF,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,39,0.93 [0.9-0.98],0.00193458905564393,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.78 [0.67-0.91],0.00201267540769265,cis
Chapter IX Diseases of the circulatory system,I9_AF,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.84 [0.76-0.94],0.0021346368116735,cis
Chapter IX Diseases of the circulatory system,I9_AF,DSC2,Desmocollin-2,Inverse variance weighted,9,0.88 [0.82-0.96],0.00260442834963999,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPON1,Spondin-1,Inverse variance weighted,21,1.07 [1.02-1.13],0.00319507685321574,cis
Chapter IX Diseases of the circulatory system,I9_AF,MATN2,Matrilin-2,Inverse variance weighted,18,1.09 [1.03-1.16],0.00452686631087454,cis
Chapter IX Diseases of the circulatory system,I9_AF,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,0.93 [0.89-0.98],0.00488970103069654,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,22,1.05 [1.01-1.08],0.00496421497512036,cis
Chapter IX Diseases of the circulatory system,I9_AF,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.07 [1.02-1.12],0.00528670811711517,cis
Chapter IX Diseases of the circulatory system,I9_AF,GHR,Growth hormone receptor,Inverse variance weighted,38,1.04 [1.01-1.07],0.00576873275747308,cis
Chapter IX Diseases of the circulatory system,I9_AF,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,0.78 [0.65-0.93],0.00643212123385615,cis
Chapter IX Diseases of the circulatory system,I9_AF,ACE,Angiotensin-converting enzyme,Inverse variance weighted,26,1.08 [1.02-1.14],0.00650748915980322,cis
Chapter IX Diseases of the circulatory system,I9_AF,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,3,1.22 [1.06-1.41],0.00697542566016092,cis
Chapter IX Diseases of the circulatory system,I9_AF,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,30,0.96 [0.93-0.99],0.00698157041436276,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCG2,Secretogranin-2,Wald ratio,1,1.76 [1.17-2.66],0.00717917887112907,cis
Chapter IX Diseases of the circulatory system,I9_AF,CNTN1,Contactin-1,Inverse variance weighted,22,0.92 [0.87-0.98],0.00735328216347698,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPON2,Spondin-2,Inverse variance weighted,4,1.12 [1.03-1.22],0.00843485982098772,cis
Chapter IX Diseases of the circulatory system,I9_AF,HIP1R,Huntingtin-interacting protein 1-related protein,Wald ratio,1,0.75 [0.6-0.93],0.00875006219051912,cis
Chapter IX Diseases of the circulatory system,I9_AF,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,2,0.86 [0.77-0.97],0.00965464026250602,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD209,CD209 antigen,Inverse variance weighted,15,0.93 [0.88-0.98],0.010274155271782,cis
Chapter IX Diseases of the circulatory system,I9_AF,APCS,Serum amyloid P-component,Inverse variance weighted,4,1.1 [1.02-1.19],0.0105605173851173,cis
Chapter IX Diseases of the circulatory system,I9_AF,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",Inverse variance weighted,6,1.19 [1.04-1.35],0.0108490956228831,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,1.57 [1.11-2.22],0.0108881309808038,cis
Chapter IX Diseases of the circulatory system,I9_AF,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.96 [0.94-0.99],0.0116914521169024,cis
Chapter IX Diseases of the circulatory system,I9_AF,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,1.2 [1.04-1.39],0.0126282443607385,cis
Chapter IX Diseases of the circulatory system,I9_AF,LMNB2,Lamin-B2,Wald ratio,1,0.54 [0.34-0.88],0.0127150246082022,cis
Chapter IX Diseases of the circulatory system,I9_AF,ITGA5,Integrin alpha-5,Wald ratio,1,0.66 [0.48-0.92],0.0139892387522704,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,8,1.15 [1.03-1.29],0.014365864534174,cis
Chapter IX Diseases of the circulatory system,I9_AF,CSTB,Cystatin-B,Inverse variance weighted,28,1.05 [1.01-1.09],0.0160531872678768,cis
Chapter IX Diseases of the circulatory system,I9_AF,C7,Complement component C7,Inverse variance weighted,38,1.03 [1.01-1.05],0.0166875912150127,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G1B,Phospholipase A2,Wald ratio,1,0.66 [0.47-0.93],0.0166985377901377,cis
Chapter IX Diseases of the circulatory system,I9_AF,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,19,0.95 [0.91-0.99],0.0167539773779998,cis
Chapter IX Diseases of the circulatory system,I9_AF,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,16,1.06 [1.01-1.11],0.017103905749881,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,8,0.92 [0.87-0.99],0.0171316164379144,cis
Chapter IX Diseases of the circulatory system,I9_AF,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,7,1.08 [1.01-1.15],0.0196327611756888,cis
Chapter IX Diseases of the circulatory system,I9_AF,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.05 [1.01-1.1],0.0196787497580427,cis
Chapter IX Diseases of the circulatory system,I9_AF,F7,Coagulation factor VII,Inverse variance weighted,21,1.06 [1.01-1.11],0.0206277421076844,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,3,1.42 [1.05-1.93],0.0218858393791448,cis
Chapter IX Diseases of the circulatory system,I9_AF,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,1.04 [1.01-1.07],0.0223937568170811,cis
Chapter IX Diseases of the circulatory system,I9_AF,UMOD,Uromodulin,Inverse variance weighted,29,1.03 [1-1.06],0.0236735296269861,cis
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,0.97 [0.94-1],0.0240227265761243,cis
Chapter IX Diseases of the circulatory system,I9_AF,MEP1B,Meprin A subunit beta,Inverse variance weighted,46,1.02 [1-1.05],0.0256630023875004,cis
Chapter IX Diseases of the circulatory system,I9_AF,STC2,Stanniocalcin-2,Inverse variance weighted,3,0.79 [0.64-0.97],0.0274625851299886,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,50,0.98 [0.96-1],0.0288144763439283,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCN3,CCN family member 3,Inverse variance weighted,19,1.1 [1.01-1.2],0.0301138257094548,cis
Chapter IX Diseases of the circulatory system,I9_AF,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,5,0.91 [0.83-0.99],0.0302746412164401,cis
Chapter IX Diseases of the circulatory system,I9_AF,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,0.94 [0.89-0.99],0.0307038569408735,cis
Chapter IX Diseases of the circulatory system,I9_AF,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,0.88 [0.78-0.99],0.0329764080176501,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.11 [1.01-1.22],0.0334136506139635,cis
Chapter IX Diseases of the circulatory system,I9_AF,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,10,0.95 [0.9-1],0.033547609563313,cis
Chapter IX Diseases of the circulatory system,I9_AF,TYRO3,Tyrosine-protein kinase receptor TYRO3,Inverse variance weighted,33,1.05 [1-1.09],0.0340845527764263,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,6,1.17 [1.01-1.35],0.0343437514571525,cis
Chapter IX Diseases of the circulatory system,I9_AF,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,4,1.09 [1.01-1.19],0.0361005332313727,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,0.88 [0.78-0.99],0.0372125299855513,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLK14,Kallikrein-14,Inverse variance weighted,15,1.05 [1-1.1],0.0372613881320802,cis
Chapter IX Diseases of the circulatory system,I9_AF,SEL1L,Protein sel-1 homolog 1,Wald ratio,1,1.07 [1-1.14],0.0377958817325089,cis
Chapter IX Diseases of the circulatory system,I9_AF,REN,Renin,Inverse variance weighted,4,1.08 [1-1.15],0.0377972751546707,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.87 [0.76-0.99],0.038624507626305,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,0.93 [0.86-1],0.0403266989851421,cis
Chapter IX Diseases of the circulatory system,I9_AF,NOS1,"Nitric oxide synthase, brain",Inverse variance weighted,2,0.84 [0.71-0.99],0.0403634515837281,cis
Chapter IX Diseases of the circulatory system,I9_AF,PALM2,Paralemmin-2,Inverse variance weighted,8,1.1 [1-1.2],0.0413331661066186,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,30,0.96 [0.92-1],0.0421498233320131,cis
Chapter IX Diseases of the circulatory system,I9_AF,VSNL1,Visinin-like protein 1,Inverse variance weighted,8,0.85 [0.72-1],0.0435113022861068,cis
Chapter IX Diseases of the circulatory system,I9_AF,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Inverse variance weighted,18,0.95 [0.9-1],0.0499762282403232,cis
Chapter IX Diseases of the circulatory system,I9_AF,AOC3,Membrane primary amine oxidase,Inverse variance weighted,18,1.04 [1-1.09],0.051915890646002,cis
Chapter IX Diseases of the circulatory system,I9_AF,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.63 [0.4-1],0.0523907333439942,cis
Chapter IX Diseases of the circulatory system,I9_AF,SEPTIN8,Septin-8,Inverse variance weighted,2,0.87 [0.76-1],0.053248496283117,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD160,CD160 antigen,Inverse variance weighted,11,0.95 [0.91-1],0.0540993605161029,cis
Chapter IX Diseases of the circulatory system,I9_AF,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.95 [0.89-1],0.0569114993098913,cis
Chapter IX Diseases of the circulatory system,I9_AF,OSM,Oncostatin-M,Wald ratio,1,1.31 [0.99-1.74],0.056983435672651,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.89 [0.8-1],0.0576799227720136,cis
Chapter IX Diseases of the circulatory system,I9_AF,PI16,Peptidase inhibitor 16,Inverse variance weighted,15,0.94 [0.88-1],0.060484844508357,cis
Chapter IX Diseases of the circulatory system,I9_AF,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.08 [1-1.17],0.0605306680448017,cis
Chapter IX Diseases of the circulatory system,I9_AF,SLAMF7,SLAM family member 7,Inverse variance weighted,20,1.03 [1-1.06],0.0607823847545321,cis
Chapter IX Diseases of the circulatory system,I9_AF,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,5,1.08 [1-1.18],0.0624308376392636,cis
Chapter IX Diseases of the circulatory system,I9_AF,LDLR,Low-density lipoprotein receptor,Wald ratio,1,2.15 [0.96-4.79],0.0629100589230235,cis
Chapter IX Diseases of the circulatory system,I9_AF,RNASE4,Ribonuclease 4,Inverse variance weighted,11,1.05 [1-1.11],0.0638671127267501,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,2,0.88 [0.77-1.01],0.0650493216407645,cis
Chapter IX Diseases of the circulatory system,I9_AF,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,19,1.02 [1-1.05],0.0668832493359731,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNN,Tenascin-N,Inverse variance weighted,44,1.02 [1-1.05],0.0708972235357919,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,7,1.12 [0.99-1.26],0.070975372387858,cis
Chapter IX Diseases of the circulatory system,I9_AF,RNASE10,Inactive ribonuclease-like protein 10,Inverse variance weighted,25,1.02 [1-1.05],0.0710375336126697,cis
Chapter IX Diseases of the circulatory system,I9_AF,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,12,0.95 [0.91-1],0.0712037089780819,cis
Chapter IX Diseases of the circulatory system,I9_AF,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,5,1.11 [0.99-1.24],0.0719654474693821,cis
Chapter IX Diseases of the circulatory system,I9_AF,EGFLAM,Pikachurin,Inverse variance weighted,19,1.03 [1-1.06],0.0720104667748136,cis
Chapter IX Diseases of the circulatory system,I9_AF,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,0.79 [0.62-1.02],0.072012228380861,cis
Chapter IX Diseases of the circulatory system,I9_AF,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Wald ratio,1,0.87 [0.75-1.01],0.0730377503277978,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.81 [0.64-1.02],0.0741290309538297,cis
Chapter IX Diseases of the circulatory system,I9_AF,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,12,0.94 [0.88-1.01],0.0768042168534886,cis
Chapter IX Diseases of the circulatory system,I9_AF,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,10,1.06 [0.99-1.14],0.0798364476549471,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,3,0.85 [0.71-1.02],0.0801007874211035,cis
Chapter IX Diseases of the circulatory system,I9_AF,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Inverse variance weighted,10,1.06 [0.99-1.13],0.0823739080816691,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,0.84 [0.69-1.02],0.0824041621907842,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,0.81 [0.64-1.03],0.082666527035033,cis
Chapter IX Diseases of the circulatory system,I9_AF,XCL1,Lymphotactin,Inverse variance weighted,31,0.97 [0.95-1],0.0858912613659231,cis
Chapter IX Diseases of the circulatory system,I9_AF,RTBDN,Retbindin,Inverse variance weighted,3,0.91 [0.82-1.01],0.0871577505599264,cis
Chapter IX Diseases of the circulatory system,I9_AF,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.05 [0.99-1.1],0.0882361855111558,cis
Chapter IX Diseases of the circulatory system,I9_AF,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,24,1.04 [0.99-1.09],0.0919671327239721,cis
Chapter IX Diseases of the circulatory system,I9_AF,PGA4,Pepsin A-4,Inverse variance weighted,2,1.25 [0.96-1.61],0.0943766712894461,cis
Chapter IX Diseases of the circulatory system,I9_AF,CFD,Complement factor D,Inverse variance weighted,11,1.05 [0.99-1.12],0.0943875765640078,cis
Chapter IX Diseases of the circulatory system,I9_AF,PXN,Paxillin,Inverse variance weighted,26,0.96 [0.92-1.01],0.0945489456972308,cis
Chapter IX Diseases of the circulatory system,I9_AF,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,2,1.12 [0.98-1.27],0.0953862397723469,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,12,1.05 [0.99-1.1],0.0971985841798122,cis
Chapter IX Diseases of the circulatory system,I9_AF,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1.02 [1-1.05],0.0982592373205219,cis
Chapter IX Diseases of the circulatory system,I9_AF,NCAN,Neurocan core protein,Inverse variance weighted,3,1.12 [0.98-1.27],0.0985030806627752,cis
Chapter IX Diseases of the circulatory system,I9_AF,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,2,0.8 [0.61-1.04],0.100195022888235,cis
Chapter IX Diseases of the circulatory system,I9_AF,SELENOP,Selenoprotein P,Inverse variance weighted,2,1.21 [0.96-1.53],0.100524520428926,cis
Chapter IX Diseases of the circulatory system,I9_AF,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,5,1.08 [0.99-1.18],0.100619997587314,cis
Chapter IX Diseases of the circulatory system,I9_AF,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Wald ratio,1,0.93 [0.85-1.01],0.101450191510236,cis
Chapter IX Diseases of the circulatory system,I9_AF,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,22,1.04 [0.99-1.08],0.101588762808848,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRG2,Bone marrow proteoglycan,Wald ratio,1,1.23 [0.96-1.58],0.103116659540819,cis
Chapter IX Diseases of the circulatory system,I9_AF,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,30,0.97 [0.93-1.01],0.103235813816281,cis
Chapter IX Diseases of the circulatory system,I9_AF,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,1.04 [0.99-1.09],0.104185098770439,cis
Chapter IX Diseases of the circulatory system,I9_AF,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,26,0.94 [0.87-1.01],0.104561376514981,cis
Chapter IX Diseases of the circulatory system,I9_AF,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,12,1.08 [0.98-1.19],0.104896878166898,cis
Chapter IX Diseases of the circulatory system,I9_AF,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.96 [0.91-1.01],0.10574967343114,cis
Chapter IX Diseases of the circulatory system,I9_AF,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.92 [0.84-1.02],0.109500690186329,cis
Chapter IX Diseases of the circulatory system,I9_AF,PVR,Poliovirus receptor,Inverse variance weighted,27,1.02 [0.99-1.05],0.110570529300043,cis
Chapter IX Diseases of the circulatory system,I9_AF,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,1.11 [0.98-1.25],0.111022219535733,cis
Chapter IX Diseases of the circulatory system,I9_AF,FCRLB,Fc receptor-like B,Inverse variance weighted,61,1.02 [1-1.05],0.115960130456495,cis
Chapter IX Diseases of the circulatory system,I9_AF,APOA2,Apolipoprotein A-II,Wald ratio,1,0.79 [0.59-1.06],0.118383268265608,cis
Chapter IX Diseases of the circulatory system,I9_AF,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,1.28 [0.94-1.74],0.118923327055534,cis
Chapter IX Diseases of the circulatory system,I9_AF,EGLN1,Egl nine homolog 1,Inverse variance weighted,3,0.9 [0.78-1.03],0.120327034020933,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,0.95 [0.9-1.01],0.126004017807715,cis
Chapter IX Diseases of the circulatory system,I9_AF,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,17,0.96 [0.92-1.01],0.126226182427609,cis
Chapter IX Diseases of the circulatory system,I9_AF,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.96 [0.91-1.01],0.128023778363352,cis
Chapter IX Diseases of the circulatory system,I9_AF,LAMB1,Laminin subunit beta-1,Inverse variance weighted,35,1.03 [0.99-1.06],0.128030325487645,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,1.05 [0.99-1.11],0.128104635233826,cis
Chapter IX Diseases of the circulatory system,I9_AF,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.39 [0.91-2.12],0.129797043431059,cis
Chapter IX Diseases of the circulatory system,I9_AF,CHCHD6,MICOS complex subunit MIC25,Inverse variance weighted,4,0.94 [0.87-1.02],0.131330345452823,cis
Chapter IX Diseases of the circulatory system,I9_AF,LGALS4,Galectin-4,Inverse variance weighted,4,0.91 [0.8-1.03],0.132180758121454,cis
Chapter IX Diseases of the circulatory system,I9_AF,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,8,0.9 [0.78-1.03],0.132385265617341,cis
Chapter IX Diseases of the circulatory system,I9_AF,ASAH2,Neutral ceramidase,Inverse variance weighted,40,0.97 [0.93-1.01],0.132392066676051,cis
Chapter IX Diseases of the circulatory system,I9_AF,SEMA7A,Semaphorin-7A,Inverse variance weighted,5,0.86 [0.7-1.05],0.13496745044708,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL23,C-C motif chemokine 23,Inverse variance weighted,17,1.03 [0.99-1.07],0.136606429846645,cis
Chapter IX Diseases of the circulatory system,I9_AF,CDH6,Cadherin-6,Inverse variance weighted,29,1.02 [0.99-1.06],0.138903803288372,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.04 [0.99-1.1],0.144921198633542,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,5,1.08 [0.97-1.21],0.146560023108975,cis
Chapter IX Diseases of the circulatory system,I9_AF,CHGB,Secretogranin-1,Inverse variance weighted,27,0.97 [0.93-1.01],0.147637429396308,cis
Chapter IX Diseases of the circulatory system,I9_AF,DCTPP1,dCTP pyrophosphatase 1,Wald ratio,1,0.73 [0.47-1.12],0.148008276855475,cis
Chapter IX Diseases of the circulatory system,I9_AF,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,16,1.04 [0.99-1.09],0.148457016292924,cis
Chapter IX Diseases of the circulatory system,I9_AF,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,34,1.02 [0.99-1.04],0.150205060574494,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD302,CD302 antigen,Inverse variance weighted,9,0.95 [0.89-1.02],0.150574990037168,cis
Chapter IX Diseases of the circulatory system,I9_AF,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,11,1.05 [0.98-1.11],0.151795229918016,cis
Chapter IX Diseases of the circulatory system,I9_AF,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,26,1.04 [0.98-1.1],0.152730328570735,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC3B,Tetranectin,Inverse variance weighted,7,0.94 [0.86-1.02],0.153277261810208,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,4,1.06 [0.98-1.15],0.15561948861372,cis
Chapter IX Diseases of the circulatory system,I9_AF,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,41,0.99 [0.97-1.01],0.155933641268436,cis
Chapter IX Diseases of the circulatory system,I9_AF,BGLAP,Osteocalcin,Inverse variance weighted,2,0.69 [0.41-1.15],0.156883461235843,cis
Chapter IX Diseases of the circulatory system,I9_AF,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,9,0.95 [0.88-1.02],0.157684253213282,cis
Chapter IX Diseases of the circulatory system,I9_AF,CGA,Glycoprotein hormones alpha chain,Wald ratio,1,1.5 [0.85-2.65],0.158615634723003,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.97 [0.94-1.01],0.159649719128646,cis
Chapter IX Diseases of the circulatory system,I9_AF,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,24,0.97 [0.94-1.01],0.161562557161518,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANXA10,Annexin A10,Wald ratio,1,1.31 [0.9-1.92],0.162517557659338,cis
Chapter IX Diseases of the circulatory system,I9_AF,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.88 [0.73-1.05],0.163005996114004,cis
Chapter IX Diseases of the circulatory system,I9_AF,FRZB,Secreted frizzled-related protein 3,Inverse variance weighted,21,0.97 [0.92-1.01],0.16453254479104,cis
Chapter IX Diseases of the circulatory system,I9_AF,NFASC,Neurofascin,Inverse variance weighted,15,0.97 [0.92-1.01],0.164837560565421,cis
Chapter IX Diseases of the circulatory system,I9_AF,HNMT,Histamine N-methyltransferase,Inverse variance weighted,27,1.02 [0.99-1.05],0.164968985215854,cis
Chapter IX Diseases of the circulatory system,I9_AF,CALCA,Calcitonin,Inverse variance weighted,5,0.88 [0.73-1.06],0.165941630697336,cis
Chapter IX Diseases of the circulatory system,I9_AF,ATRN,"Attractin, Isoform 2",Inverse variance weighted,12,1.03 [0.99-1.09],0.167200227196709,cis
Chapter IX Diseases of the circulatory system,I9_AF,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.94 [0.86-1.03],0.169020088059159,cis
Chapter IX Diseases of the circulatory system,I9_AF,NECTIN4,Nectin-4,Inverse variance weighted,7,1.05 [0.98-1.13],0.169313067465119,cis
Chapter IX Diseases of the circulatory system,I9_AF,CTSS,Cathepsin S,Inverse variance weighted,23,1.03 [0.99-1.07],0.169871836546282,cis
Chapter IX Diseases of the circulatory system,I9_AF,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,1.05 [0.98-1.13],0.171982133890275,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLK11,Kallikrein-11,Inverse variance weighted,6,1.03 [0.99-1.08],0.175130084383561,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,1.23 [0.91-1.67],0.176049846335449,cis
Chapter IX Diseases of the circulatory system,I9_AF,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.92 [0.82-1.04],0.177897422690458,cis
Chapter IX Diseases of the circulatory system,I9_AF,RSPO3,R-spondin-3,Inverse variance weighted,6,0.93 [0.83-1.04],0.179245549378383,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD7,T-cell antigen CD7,Inverse variance weighted,8,0.97 [0.93-1.01],0.180093714498537,cis
Chapter IX Diseases of the circulatory system,I9_AF,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,27,1.02 [0.99-1.06],0.181639814034992,cis
Chapter IX Diseases of the circulatory system,I9_AF,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,27,0.98 [0.95-1.01],0.183191807396299,cis
Chapter IX Diseases of the circulatory system,I9_AF,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,0.96 [0.9-1.02],0.184148104221853,cis
Chapter IX Diseases of the circulatory system,I9_AF,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,14,1.08 [0.96-1.2],0.187216041190549,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.03 [0.98-1.09],0.187269817177905,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.02 [0.99-1.04],0.188176445453774,cis
Chapter IX Diseases of the circulatory system,I9_AF,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.08 [0.96-1.21],0.189270772926911,cis
Chapter IX Diseases of the circulatory system,I9_AF,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,8,0.92 [0.81-1.04],0.190088118557629,cis
Chapter IX Diseases of the circulatory system,I9_AF,MTUS1,Microtubule-associated tumor suppressor 1,Inverse variance weighted,5,1.14 [0.94-1.39],0.192720541903269,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.96 [0.91-1.02],0.192876297716586,cis
Chapter IX Diseases of the circulatory system,I9_AF,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,14,1.03 [0.98-1.08],0.194674855889174,cis
Chapter IX Diseases of the circulatory system,I9_AF,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,41,1.02 [0.99-1.04],0.202730961880672,cis
Chapter IX Diseases of the circulatory system,I9_AF,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Wald ratio,1,1.12 [0.94-1.33],0.202746162717516,cis
Chapter IX Diseases of the circulatory system,I9_AF,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.16 [0.92-1.47],0.203393900651301,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.03 [0.99-1.07],0.20388728112136,cis
Chapter IX Diseases of the circulatory system,I9_AF,NXPH3,Neurexophilin-3,Inverse variance weighted,11,1.04 [0.98-1.11],0.204572856277353,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRTN3,Myeloblastin,Inverse variance weighted,21,0.97 [0.92-1.02],0.204593576913912,cis
Chapter IX Diseases of the circulatory system,I9_AF,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,2,0.86 [0.69-1.08],0.207397658842127,cis
Chapter IX Diseases of the circulatory system,I9_AF,FOLR2,Folate receptor beta,Inverse variance weighted,2,1.14 [0.93-1.39],0.208137999730628,cis
Chapter IX Diseases of the circulatory system,I9_AF,CHRDL2,Chordin-like protein 2,Inverse variance weighted,7,0.93 [0.82-1.04],0.209735981818756,cis
Chapter IX Diseases of the circulatory system,I9_AF,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,1.11 [0.94-1.31],0.209847542839723,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,1.04 [0.98-1.11],0.211896058781816,cis
Chapter IX Diseases of the circulatory system,I9_AF,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,15,0.95 [0.88-1.03],0.212224017985295,cis
Chapter IX Diseases of the circulatory system,I9_AF,MMP3,Stromelysin-1,Inverse variance weighted,34,0.97 [0.92-1.02],0.213209167932127,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.96 [0.91-1.02],0.217304784186695,cis
Chapter IX Diseases of the circulatory system,I9_AF,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,1.41 [0.82-2.45],0.217945004373178,cis
Chapter IX Diseases of the circulatory system,I9_AF,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,23,1.03 [0.98-1.09],0.218912772343811,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,46,0.98 [0.96-1.01],0.221200649573907,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,3,0.93 [0.82-1.05],0.221826319278063,cis
Chapter IX Diseases of the circulatory system,I9_AF,BANK1,B-cell scaffold protein with ankyrin repeats,Inverse variance weighted,3,1.15 [0.92-1.43],0.222187965472545,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,0.98 [0.94-1.02],0.224862481899079,cis
Chapter IX Diseases of the circulatory system,I9_AF,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,1.02 [0.99-1.06],0.226231860799706,cis
Chapter IX Diseases of the circulatory system,I9_AF,CRELD1,Protein disulfide isomerase CRELD1,Inverse variance weighted,34,1.02 [0.99-1.06],0.227059161966479,cis
Chapter IX Diseases of the circulatory system,I9_AF,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,1.05 [0.97-1.13],0.227306377815675,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANXA5,Annexin A5,Inverse variance weighted,2,1.12 [0.93-1.34],0.22774686012978,cis
Chapter IX Diseases of the circulatory system,I9_AF,RBP7,Retinoid-binding protein 7,Inverse variance weighted,8,0.91 [0.78-1.06],0.227933654871758,cis
Chapter IX Diseases of the circulatory system,I9_AF,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,0.9 [0.76-1.07],0.230430847156664,cis
Chapter IX Diseases of the circulatory system,I9_AF,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.92 [0.81-1.05],0.231623527252688,cis
Chapter IX Diseases of the circulatory system,I9_AF,MYOM2,Myomesin-2,Inverse variance weighted,2,1.18 [0.9-1.54],0.231953360950284,cis
Chapter IX Diseases of the circulatory system,I9_AF,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,8,1.06 [0.97-1.15],0.236165131398191,cis
Chapter IX Diseases of the circulatory system,I9_AF,LEFTY2,Left-right determination factor 2,Inverse variance weighted,36,1.02 [0.99-1.04],0.236886799621828,cis
Chapter IX Diseases of the circulatory system,I9_AF,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,15,1.05 [0.97-1.14],0.236911036911362,cis
Chapter IX Diseases of the circulatory system,I9_AF,RSPO1,R-spondin-1,Inverse variance weighted,5,1.07 [0.96-1.2],0.237799466460128,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL18,C-C motif chemokine 18,Inverse variance weighted,15,1.02 [0.99-1.06],0.239204784568677,cis
Chapter IX Diseases of the circulatory system,I9_AF,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,16,1.02 [0.98-1.06],0.239554077713758,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,8,0.96 [0.9-1.03],0.240007745158506,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,9,1.07 [0.96-1.2],0.240384254252419,cis
Chapter IX Diseases of the circulatory system,I9_AF,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.98 [0.93-1.02],0.243381051866185,cis
Chapter IX Diseases of the circulatory system,I9_AF,CPM,Carboxypeptidase M,Inverse variance weighted,4,1.07 [0.95-1.21],0.245177573435965,cis
Chapter IX Diseases of the circulatory system,I9_AF,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,10,1.04 [0.98-1.1],0.245540105963523,cis
Chapter IX Diseases of the circulatory system,I9_AF,ROBO1,Roundabout homolog 1,Inverse variance weighted,10,0.94 [0.84-1.04],0.248205770660927,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Wald ratio,1,0.73 [0.43-1.24],0.248859132761451,cis
Chapter IX Diseases of the circulatory system,I9_AF,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,Inverse variance weighted,11,0.96 [0.89-1.03],0.249360495606497,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,12,1.06 [0.96-1.17],0.251353202893139,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,0.98 [0.95-1.01],0.256030941665859,cis
Chapter IX Diseases of the circulatory system,I9_AF,PSAP,Prosaposin,Inverse variance weighted,5,1.07 [0.95-1.2],0.259361295804548,cis
Chapter IX Diseases of the circulatory system,I9_AF,VWC2,Brorin,Inverse variance weighted,22,1.03 [0.98-1.09],0.259581883255765,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLKB1,Plasma kallikrein,Inverse variance weighted,15,1.02 [0.98-1.07],0.260751564080676,cis
Chapter IX Diseases of the circulatory system,I9_AF,CST3,Cystatin-C,Inverse variance weighted,10,1.04 [0.97-1.12],0.261788521380487,cis
Chapter IX Diseases of the circulatory system,I9_AF,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,55,1.01 [0.99-1.03],0.263198657391838,cis
Chapter IX Diseases of the circulatory system,I9_AF,PGF,Placenta growth factor,Inverse variance weighted,2,0.75 [0.45-1.25],0.266093511549182,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,11,0.97 [0.91-1.03],0.271969610292862,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRSS2,Trypsin-2,Inverse variance weighted,3,1.07 [0.95-1.21],0.272279706015726,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,4,0.95 [0.86-1.04],0.272953755271193,cis
Chapter IX Diseases of the circulatory system,I9_AF,MMP7,Matrilysin,Inverse variance weighted,13,1.03 [0.98-1.08],0.273859119353283,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,16,0.97 [0.91-1.03],0.275154829774271,cis
Chapter IX Diseases of the circulatory system,I9_AF,TG,Thyroglobulin,Inverse variance weighted,2,1.16 [0.89-1.5],0.275760556128622,cis
Chapter IX Diseases of the circulatory system,I9_AF,MMP10,Stromelysin-2,Inverse variance weighted,22,0.97 [0.91-1.03],0.276703831454688,cis
Chapter IX Diseases of the circulatory system,I9_AF,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,0.9 [0.74-1.09],0.276971393510088,cis
Chapter IX Diseases of the circulatory system,I9_AF,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,19,1.02 [0.98-1.07],0.277205420888989,cis
Chapter IX Diseases of the circulatory system,I9_AF,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,1.02 [0.99-1.05],0.278064997296832,cis
Chapter IX Diseases of the circulatory system,I9_AF,DLL1,Delta-like protein 1,Inverse variance weighted,7,0.95 [0.87-1.04],0.278212636429661,cis
Chapter IX Diseases of the circulatory system,I9_AF,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.26 [0.83-1.91],0.278438242597089,cis
Chapter IX Diseases of the circulatory system,I9_AF,TCOF1,Treacle protein,Wald ratio,1,0.81 [0.55-1.19],0.280758428439992,cis
Chapter IX Diseases of the circulatory system,I9_AF,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,Wald ratio,1,0.84 [0.61-1.15],0.281902628004089,cis
Chapter IX Diseases of the circulatory system,I9_AF,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,0.98 [0.96-1.01],0.282424349830893,cis
Chapter IX Diseases of the circulatory system,I9_AF,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,1.06 [0.95-1.19],0.282963373627452,cis
Chapter IX Diseases of the circulatory system,I9_AF,HGF,Hepatocyte growth factor,Inverse variance weighted,2,0.89 [0.72-1.1],0.283338579741531,cis
Chapter IX Diseases of the circulatory system,I9_AF,PCDH17,Protocadherin-17,Inverse variance weighted,2,0.92 [0.78-1.07],0.283443056394861,cis
Chapter IX Diseases of the circulatory system,I9_AF,NECTIN2,Nectin-2,Inverse variance weighted,5,0.94 [0.83-1.06],0.285610541111669,cis
Chapter IX Diseases of the circulatory system,I9_AF,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,0.95 [0.87-1.04],0.286512648342328,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,4,1.1 [0.92-1.3],0.288403885116447,cis
Chapter IX Diseases of the circulatory system,I9_AF,GSR,"Glutathione reductase, mitochondrial",Wald ratio,1,1.04 [0.97-1.1],0.291451091819975,cis
Chapter IX Diseases of the circulatory system,I9_AF,PTN,Pleiotrophin,Inverse variance weighted,4,0.88 [0.7-1.11],0.293058362630887,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,0.95 [0.87-1.05],0.296481758477651,cis
Chapter IX Diseases of the circulatory system,I9_AF,PKD1,Polycystin-1,Inverse variance weighted,12,0.96 [0.89-1.04],0.296817632346912,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,1.16 [0.87-1.55],0.303738579773238,cis
Chapter IX Diseases of the circulatory system,I9_AF,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,28,0.98 [0.95-1.02],0.305408975810756,cis
Chapter IX Diseases of the circulatory system,I9_AF,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.93-1.02],0.305951969696541,cis
Chapter IX Diseases of the circulatory system,I9_AF,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,8,0.96 [0.87-1.04],0.310212669170688,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,1.06 [0.95-1.17],0.311150286483858,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRELP,Prolargin,Inverse variance weighted,9,0.97 [0.92-1.03],0.313934528717466,cis
Chapter IX Diseases of the circulatory system,I9_AF,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,4,0.97 [0.91-1.03],0.314576195276807,cis
Chapter IX Diseases of the circulatory system,I9_AF,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,1.17 [0.86-1.58],0.316350341479161,cis
Chapter IX Diseases of the circulatory system,I9_AF,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,1.04 [0.96-1.13],0.317294325834585,cis
Chapter IX Diseases of the circulatory system,I9_AF,PI3,Elafin,Inverse variance weighted,10,1.03 [0.97-1.1],0.320089049412375,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,0.93 [0.8-1.08],0.320922357889262,cis
Chapter IX Diseases of the circulatory system,I9_AF,SNCG,Gamma-synuclein,Inverse variance weighted,36,0.98 [0.94-1.02],0.323045891972459,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,7,1.04 [0.96-1.12],0.325300728001353,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD27,CD27 antigen,Inverse variance weighted,9,1.03 [0.97-1.09],0.326550829623772,cis
Chapter IX Diseases of the circulatory system,I9_AF,ITGAM,Integrin alpha-M,Inverse variance weighted,3,0.95 [0.84-1.06],0.328828387775681,cis
Chapter IX Diseases of the circulatory system,I9_AF,TPMT,Thiopurine S-methyltransferase,Inverse variance weighted,10,1.03 [0.97-1.11],0.32915796319265,cis
Chapter IX Diseases of the circulatory system,I9_AF,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.87 [0.65-1.16],0.329459122777918,cis
Chapter IX Diseases of the circulatory system,I9_AF,MCAM,Cell surface glycoprotein MUC18,Wald ratio,1,1.07 [0.93-1.24],0.331382245371268,cis
Chapter IX Diseases of the circulatory system,I9_AF,MUC13,Mucin-13,Inverse variance weighted,9,1.04 [0.96-1.12],0.33299510968263,cis
Chapter IX Diseases of the circulatory system,I9_AF,FCN2,Ficolin-2,Inverse variance weighted,25,1.02 [0.98-1.05],0.33487585639728,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,0.98 [0.94-1.02],0.335710216159719,cis
Chapter IX Diseases of the circulatory system,I9_AF,ENG,Endoglin,Inverse variance weighted,9,0.97 [0.91-1.03],0.337694397809384,cis
Chapter IX Diseases of the circulatory system,I9_AF,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.03 [0.97-1.09],0.339072801142218,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL15,Interleukin-15,Wald ratio,1,0.4 [0.06-2.59],0.33938274503474,cis
Chapter IX Diseases of the circulatory system,I9_AF,ACHE,Acetylcholinesterase,Inverse variance weighted,22,1.04 [0.96-1.12],0.341180079826196,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,16,0.95 [0.85-1.06],0.341654098140298,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPPB,Natriuretic peptides B,Inverse variance weighted,3,1.05 [0.95-1.17],0.342750600637241,cis
Chapter IX Diseases of the circulatory system,I9_AF,RRM2,Ribonucleoside-diphosphate reductase subunit M2,Wald ratio,1,0.83 [0.56-1.23],0.345975176610991,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.97-1.01],0.347630583384668,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.09 [0.91-1.29],0.349750626932548,cis
Chapter IX Diseases of the circulatory system,I9_AF,BCAN,Brevican core protein,Inverse variance weighted,3,1.05 [0.95-1.16],0.354112942241198,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.02 [0.98-1.06],0.354296914938711,cis
Chapter IX Diseases of the circulatory system,I9_AF,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,9,0.97 [0.91-1.03],0.357554649077431,cis
Chapter IX Diseases of the circulatory system,I9_AF,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,1.06 [0.94-1.2],0.359767703404335,cis
Chapter IX Diseases of the circulatory system,I9_AF,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.11 [0.88-1.4],0.359914919235144,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,2,0.68 [0.3-1.55],0.362169458107886,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.02 [0.97-1.08],0.363625822156331,cis
Chapter IX Diseases of the circulatory system,I9_AF,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.98 [0.95-1.02],0.363862347348793,cis
Chapter IX Diseases of the circulatory system,I9_AF,LGALS3,Galectin-3,Inverse variance weighted,25,1.02 [0.98-1.06],0.364108993429496,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,1.26 [0.76-2.09],0.366865146943165,cis
Chapter IX Diseases of the circulatory system,I9_AF,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,28,1.01 [0.98-1.04],0.366875940666686,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,8,1.06 [0.93-1.2],0.368899032434763,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,0.97 [0.92-1.03],0.36927267109067,cis
Chapter IX Diseases of the circulatory system,I9_AF,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,4,1.05 [0.95-1.16],0.370852429391954,cis
Chapter IX Diseases of the circulatory system,I9_AF,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,19,0.97 [0.91-1.04],0.370961763666163,cis
Chapter IX Diseases of the circulatory system,I9_AF,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,5,0.95 [0.85-1.06],0.375549436045192,cis
Chapter IX Diseases of the circulatory system,I9_AF,VCAN,Versican core protein,Inverse variance weighted,31,1.02 [0.98-1.05],0.375798277469566,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,4,0.89 [0.69-1.15],0.377603505039763,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,19,0.98 [0.95-1.02],0.379356143395098,cis
Chapter IX Diseases of the circulatory system,I9_AF,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.02 [0.98-1.07],0.379502983068214,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,0.81 [0.52-1.29],0.38063656913841,cis
Chapter IX Diseases of the circulatory system,I9_AF,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,15,1.02 [0.98-1.06],0.380637063529466,cis
Chapter IX Diseases of the circulatory system,I9_AF,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.98 [0.93-1.03],0.38248814271886,cis
Chapter IX Diseases of the circulatory system,I9_AF,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,Wald ratio,1,1.09 [0.9-1.32],0.383003969694789,cis
Chapter IX Diseases of the circulatory system,I9_AF,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,13,0.97 [0.91-1.04],0.384147316298828,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD300A,CMRF35-like molecule 8,Inverse variance weighted,5,1.03 [0.96-1.11],0.384371193045843,cis
Chapter IX Diseases of the circulatory system,I9_AF,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,8,0.96 [0.88-1.05],0.384640836912476,cis
Chapter IX Diseases of the circulatory system,I9_AF,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.02 [0.97-1.07],0.385766663538564,cis
Chapter IX Diseases of the circulatory system,I9_AF,CREG1,Protein CREG1,Inverse variance weighted,3,0.95 [0.86-1.06],0.387302818085955,cis
Chapter IX Diseases of the circulatory system,I9_AF,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,7,0.94 [0.82-1.08],0.38848685113108,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL16,C-C motif chemokine 16,Inverse variance weighted,19,0.99 [0.96-1.02],0.390009262432733,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,1.06 [0.93-1.19],0.39479125871156,cis
Chapter IX Diseases of the circulatory system,I9_AF,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.02 [0.98-1.06],0.402019773852811,cis
Chapter IX Diseases of the circulatory system,I9_AF,MILR1,Allergin-1,Inverse variance weighted,33,1.01 [0.99-1.03],0.404922225233189,cis
Chapter IX Diseases of the circulatory system,I9_AF,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.98 [0.92-1.03],0.406707100435888,cis
Chapter IX Diseases of the circulatory system,I9_AF,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,15,0.97 [0.91-1.04],0.40910531540285,cis
Chapter IX Diseases of the circulatory system,I9_AF,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.92 [0.76-1.12],0.411986854866342,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPL,N-acetylneuraminate lyase,Inverse variance weighted,11,1.04 [0.94-1.15],0.412477431830933,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD48,CD48 antigen,Inverse variance weighted,18,1.01 [0.98-1.05],0.414754400741858,cis
Chapter IX Diseases of the circulatory system,I9_AF,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.03 [0.95-1.12],0.415096338727328,cis
Chapter IX Diseases of the circulatory system,I9_AF,DKK3,Dickkopf-related protein 3,Inverse variance weighted,13,0.97 [0.91-1.04],0.415352063181737,cis
Chapter IX Diseases of the circulatory system,I9_AF,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.05 [0.93-1.2],0.418126459525583,cis
Chapter IX Diseases of the circulatory system,I9_AF,CTSL,Cathepsin L1,Wald ratio,1,0.84 [0.55-1.28],0.421656152571049,cis
Chapter IX Diseases of the circulatory system,I9_AF,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,9,1.05 [0.94-1.17],0.424778242112093,cis
Chapter IX Diseases of the circulatory system,I9_AF,TACC3,Transforming acidic coiled-coil-containing protein 3,Inverse variance weighted,5,0.96 [0.88-1.06],0.425102269880316,cis
Chapter IX Diseases of the circulatory system,I9_AF,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,3,1.09 [0.88-1.36],0.425451629300336,cis
Chapter IX Diseases of the circulatory system,I9_AF,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,1.03 [0.96-1.09],0.427699054707925,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,3,1.04 [0.94-1.16],0.428079830465735,cis
Chapter IX Diseases of the circulatory system,I9_AF,STC1,Stanniocalcin-1,Inverse variance weighted,2,1.18 [0.79-1.77],0.429212026833198,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCGB1A1,Uteroglobin,Inverse variance weighted,12,0.98 [0.92-1.04],0.429471154784991,cis
Chapter IX Diseases of the circulatory system,I9_AF,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,3,0.95 [0.84-1.08],0.429874775278798,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.07 [0.9-1.26],0.43185314085326,cis
Chapter IX Diseases of the circulatory system,I9_AF,CA9,Carbonic anhydrase 9,Inverse variance weighted,3,1.09 [0.88-1.36],0.432055944923107,cis
Chapter IX Diseases of the circulatory system,I9_AF,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,1.05 [0.93-1.19],0.432626806699153,cis
Chapter IX Diseases of the circulatory system,I9_AF,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,34,1.01 [0.98-1.05],0.433645297093644,cis
Chapter IX Diseases of the circulatory system,I9_AF,NRP1,Neuropilin-1,Inverse variance weighted,12,0.97 [0.9-1.05],0.4370357237494,cis
Chapter IX Diseases of the circulatory system,I9_AF,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Inverse variance weighted,4,1.03 [0.96-1.1],0.438818767952245,cis
Chapter IX Diseases of the circulatory system,I9_AF,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,4,1.04 [0.94-1.15],0.438937134620487,cis
Chapter IX Diseases of the circulatory system,I9_AF,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,0.98 [0.94-1.03],0.43959161043411,cis
Chapter IX Diseases of the circulatory system,I9_AF,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,11,1.02 [0.96-1.09],0.44267162323914,cis
Chapter IX Diseases of the circulatory system,I9_AF,VWF,von Willebrand factor,Inverse variance weighted,2,1.07 [0.9-1.26],0.447559318574255,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,3,0.98 [0.93-1.03],0.448906541235169,cis
Chapter IX Diseases of the circulatory system,I9_AF,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.95 [0.83-1.09],0.449514781122716,cis
Chapter IX Diseases of the circulatory system,I9_AF,GRPEL1,"GrpE protein homolog 1, mitochondrial",Wald ratio,1,1.15 [0.8-1.65],0.449733626974109,cis
Chapter IX Diseases of the circulatory system,I9_AF,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.95 [0.84-1.08],0.453020476417834,cis
Chapter IX Diseases of the circulatory system,I9_AF,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,7,0.97 [0.9-1.05],0.45367996194505,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLK8,Kallikrein-8,Inverse variance weighted,12,1.02 [0.97-1.08],0.458593974165454,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,17,0.97 [0.9-1.05],0.460242801890626,cis
Chapter IX Diseases of the circulatory system,I9_AF,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,5,1.05 [0.93-1.18],0.464370194087795,cis
Chapter IX Diseases of the circulatory system,I9_AF,LGALS1,Galectin-1,Inverse variance weighted,6,1.03 [0.95-1.11],0.464483628569895,cis
Chapter IX Diseases of the circulatory system,I9_AF,SDC4,Syndecan-4,Inverse variance weighted,8,1.03 [0.95-1.13],0.464965826939927,cis
Chapter IX Diseases of the circulatory system,I9_AF,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.95 [0.82-1.09],0.465179082120454,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,4,0.88 [0.62-1.25],0.467131723237636,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,0.95 [0.81-1.1],0.467942795128456,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANXA11,Annexin A11,Inverse variance weighted,2,0.92 [0.72-1.16],0.468746871333994,cis
Chapter IX Diseases of the circulatory system,I9_AF,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,33,1.02 [0.97-1.06],0.46951352095026,cis
Chapter IX Diseases of the circulatory system,I9_AF,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,2,0.92 [0.73-1.16],0.469875210088693,cis
Chapter IX Diseases of the circulatory system,I9_AF,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,8,0.97 [0.91-1.05],0.474278542857847,cis
Chapter IX Diseases of the circulatory system,I9_AF,USP28,Ubiquitin carboxyl-terminal hydrolase 28,Inverse variance weighted,2,0.8 [0.43-1.48],0.474347228504066,cis
Chapter IX Diseases of the circulatory system,I9_AF,S100A4,Protein S100-A4,Inverse variance weighted,4,1.06 [0.9-1.25],0.47445956546272,cis
Chapter IX Diseases of the circulatory system,I9_AF,B4GAT1,"Beta-1,4-glucuronyltransferase 1",Inverse variance weighted,14,1.02 [0.96-1.09],0.476704032608913,cis
Chapter IX Diseases of the circulatory system,I9_AF,SDC1,Syndecan-1,Inverse variance weighted,2,1.05 [0.91-1.21],0.478160305833929,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,Inverse variance weighted,2,0.98 [0.92-1.04],0.478961486543579,cis
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,1.02 [0.97-1.06],0.480150361033394,cis
Chapter IX Diseases of the circulatory system,I9_AF,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,1.02 [0.96-1.08],0.480183529911425,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD83,CD83 antigen,Inverse variance weighted,5,0.97 [0.88-1.06],0.480809668627329,cis
Chapter IX Diseases of the circulatory system,I9_AF,PALM,Paralemmin-1,Inverse variance weighted,6,1.04 [0.93-1.16],0.483978839683194,cis
Chapter IX Diseases of the circulatory system,I9_AF,GAL,Galanin peptides,Inverse variance weighted,3,0.9 [0.66-1.22],0.484816570376883,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.96 [0.87-1.07],0.490360886181158,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNR,Tenascin-R,Inverse variance weighted,16,0.98 [0.92-1.04],0.49364678278709,cis
Chapter IX Diseases of the circulatory system,I9_AF,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.99 [0.97-1.01],0.495725830297392,cis
Chapter IX Diseases of the circulatory system,I9_AF,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.03 [0.95-1.12],0.499355273568977,cis
Chapter IX Diseases of the circulatory system,I9_AF,CDHR5,Cadherin-related family member 5,Inverse variance weighted,28,1.01 [0.98-1.04],0.500224493405574,cis
Chapter IX Diseases of the circulatory system,I9_AF,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.07 [0.89-1.28],0.50281136458985,cis
Chapter IX Diseases of the circulatory system,I9_AF,COLEC12,Collectin-12,Inverse variance weighted,11,0.98 [0.91-1.05],0.503495266622463,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLSTN2,Calsyntenin-2,Inverse variance weighted,31,0.99 [0.95-1.02],0.5035251369126,cis
Chapter IX Diseases of the circulatory system,I9_AF,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,12,1.02 [0.95-1.1],0.503533827360677,cis
Chapter IX Diseases of the circulatory system,I9_AF,GSN,Gelsolin,Inverse variance weighted,5,1.05 [0.9-1.23],0.503735069446885,cis
Chapter IX Diseases of the circulatory system,I9_AF,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.1 [0.84-1.44],0.504942832948335,cis
Chapter IX Diseases of the circulatory system,I9_AF,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,7,0.98 [0.93-1.04],0.505961262361308,cis
Chapter IX Diseases of the circulatory system,I9_AF,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,9,1.02 [0.96-1.1],0.506915735791552,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,11,0.98 [0.92-1.04],0.507188914771209,cis
Chapter IX Diseases of the circulatory system,I9_AF,NT5C3A,Cytosolic 5'-nucleotidase 3A,Wald ratio,1,0.94 [0.77-1.13],0.507911584285764,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL17D,Interleukin-17D,Inverse variance weighted,15,1.02 [0.97-1.07],0.515340543545777,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,0.96 [0.86-1.08],0.519805987383321,cis
Chapter IX Diseases of the circulatory system,I9_AF,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,3,0.97 [0.87-1.07],0.523615691240343,cis
Chapter IX Diseases of the circulatory system,I9_AF,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,16,0.98 [0.93-1.04],0.526032811476687,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,30,1.01 [0.98-1.05],0.526198243955063,cis
Chapter IX Diseases of the circulatory system,I9_AF,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,0.94 [0.76-1.15],0.526234469725673,cis
Chapter IX Diseases of the circulatory system,I9_AF,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,26,0.99 [0.94-1.03],0.528295812951522,cis
Chapter IX Diseases of the circulatory system,I9_AF,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,9,0.97 [0.89-1.06],0.528991348592289,cis
Chapter IX Diseases of the circulatory system,I9_AF,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.96 [0.84-1.09],0.532715174325205,cis
Chapter IX Diseases of the circulatory system,I9_AF,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.11 [0.81-1.52],0.533376515568296,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.01 [0.98-1.03],0.536197450478894,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,0.99 [0.96-1.02],0.538113043962469,cis
Chapter IX Diseases of the circulatory system,I9_AF,OCLN,Occludin,Inverse variance weighted,2,1.08 [0.84-1.39],0.540745580436367,cis
Chapter IX Diseases of the circulatory system,I9_AF,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.01 [0.98-1.03],0.541740145190977,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,24,0.99 [0.95-1.03],0.545481046017368,cis
Chapter IX Diseases of the circulatory system,I9_AF,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,Inverse variance weighted,10,0.98 [0.92-1.04],0.546376131425401,cis
Chapter IX Diseases of the circulatory system,I9_AF,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.89 [0.61-1.3],0.546924687813167,cis
Chapter IX Diseases of the circulatory system,I9_AF,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Wald ratio,1,1.06 [0.89-1.26],0.54770525724082,cis
Chapter IX Diseases of the circulatory system,I9_AF,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Wald ratio,1,1.05 [0.89-1.24],0.547705257240821,cis
Chapter IX Diseases of the circulatory system,I9_AF,LY96,Lymphocyte antigen 96,Inverse variance weighted,3,0.87 [0.56-1.36],0.548260140716078,cis
Chapter IX Diseases of the circulatory system,I9_AF,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,22,0.99 [0.94-1.03],0.549040547632054,cis
Chapter IX Diseases of the circulatory system,I9_AF,AGRP,Agouti-related protein,Inverse variance weighted,3,1.11 [0.79-1.55],0.549374616282542,cis
Chapter IX Diseases of the circulatory system,I9_AF,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,16,0.99 [0.95-1.03],0.559498914341374,cis
Chapter IX Diseases of the circulatory system,I9_AF,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,0.95 [0.82-1.12],0.562092091093311,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD34,Hematopoietic progenitor cell antigen CD34,Wald ratio,1,1.1 [0.79-1.54],0.563389220470773,cis
Chapter IX Diseases of the circulatory system,I9_AF,APOC1,Apolipoprotein C-I,Inverse variance weighted,6,1.04 [0.9-1.21],0.563518944867478,cis
Chapter IX Diseases of the circulatory system,I9_AF,GPC5,Glypican-5,Inverse variance weighted,33,0.99 [0.96-1.02],0.565565595807287,cis
Chapter IX Diseases of the circulatory system,I9_AF,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,1.06 [0.87-1.28],0.569663521741722,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,2,0.93 [0.73-1.19],0.570430091695774,cis
Chapter IX Diseases of the circulatory system,I9_AF,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,27,1.01 [0.98-1.04],0.570470957762485,cis
Chapter IX Diseases of the circulatory system,I9_AF,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.03 [0.94-1.12],0.570588222767607,cis
Chapter IX Diseases of the circulatory system,I9_AF,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.99 [0.96-1.02],0.573132819930616,cis
Chapter IX Diseases of the circulatory system,I9_AF,MSLN,Mesothelin,Inverse variance weighted,25,1.01 [0.98-1.04],0.574079704281603,cis
Chapter IX Diseases of the circulatory system,I9_AF,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,8,0.98 [0.92-1.05],0.576240697108674,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,13,0.98 [0.93-1.04],0.57628047273239,cis
Chapter IX Diseases of the circulatory system,I9_AF,GPRC5C,G-protein coupled receptor family C group 5 member C,Wald ratio,1,1.05 [0.88-1.25],0.57698840222205,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.01 [0.98-1.04],0.579505086240082,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.02 [0.94-1.11],0.581451224448906,cis
Chapter IX Diseases of the circulatory system,I9_AF,THPO,Thrombopoietin,Inverse variance weighted,3,1.07 [0.84-1.35],0.586716655424026,cis
Chapter IX Diseases of the circulatory system,I9_AF,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.01 [0.97-1.05],0.587312326922061,cis
Chapter IX Diseases of the circulatory system,I9_AF,CR2,Complement receptor type 2,Inverse variance weighted,6,1.03 [0.94-1.12],0.589866764850364,cis
Chapter IX Diseases of the circulatory system,I9_AF,EFNA1,Ephrin-A1,Inverse variance weighted,11,1.04 [0.9-1.19],0.591192442076788,cis
Chapter IX Diseases of the circulatory system,I9_AF,EPO,Erythropoietin,Inverse variance weighted,5,0.89 [0.6-1.34],0.592466391921285,cis
Chapter IX Diseases of the circulatory system,I9_AF,FAM3B,Protein FAM3B,Inverse variance weighted,18,1.01 [0.98-1.04],0.592896588674098,cis
Chapter IX Diseases of the circulatory system,I9_AF,S100P,Protein S100-P,Inverse variance weighted,2,0.93 [0.72-1.21],0.596190936513687,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,21,0.99 [0.95-1.03],0.596340451200098,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.96 [0.83-1.11],0.597621821453517,cis
Chapter IX Diseases of the circulatory system,I9_AF,RBP2,Retinol-binding protein 2,Wald ratio,1,1.09 [0.79-1.5],0.59831266111398,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCN5,CCN family member 5,Inverse variance weighted,8,0.96 [0.81-1.13],0.598443123915012,cis
Chapter IX Diseases of the circulatory system,I9_AF,TMEM25,Transmembrane protein 25,Inverse variance weighted,8,0.99 [0.93-1.04],0.598544489846526,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.03 [0.91-1.17],0.602819979130966,cis
Chapter IX Diseases of the circulatory system,I9_AF,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,15,0.99 [0.94-1.03],0.606586522349253,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPOCK1,Testican-1,Inverse variance weighted,6,1.03 [0.91-1.18],0.608183883977809,cis
Chapter IX Diseases of the circulatory system,I9_AF,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,0.97 [0.84-1.11],0.613067862623332,cis
Chapter IX Diseases of the circulatory system,I9_AF,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,0.98 [0.9-1.06],0.613567103249262,cis
Chapter IX Diseases of the circulatory system,I9_AF,HSPB6,Heat shock protein beta-6,Wald ratio,1,0.88 [0.54-1.43],0.614702731587561,cis
Chapter IX Diseases of the circulatory system,I9_AF,CNTN5,Contactin-5,Inverse variance weighted,28,1.01 [0.98-1.04],0.617233673496367,cis
Chapter IX Diseases of the circulatory system,I9_AF,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.02 [0.94-1.11],0.619243392348449,cis
Chapter IX Diseases of the circulatory system,I9_AF,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.99 [0.94-1.04],0.619262297099626,cis
Chapter IX Diseases of the circulatory system,I9_AF,GUCA2A,Guanylin,Inverse variance weighted,9,1.03 [0.93-1.14],0.619552318595057,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,1.03 [0.92-1.15],0.620111508807777,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,0.98 [0.91-1.06],0.620213200394002,cis
Chapter IX Diseases of the circulatory system,I9_AF,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,31,0.99 [0.96-1.03],0.620281563080519,cis
Chapter IX Diseases of the circulatory system,I9_AF,THY1,Thy-1 membrane glycoprotein,Inverse variance weighted,10,1.01 [0.97-1.05],0.620646600584869,cis
Chapter IX Diseases of the circulatory system,I9_AF,EDN1,Endothelin-1,Inverse variance weighted,3,0.96 [0.83-1.12],0.621448550157385,cis
Chapter IX Diseases of the circulatory system,I9_AF,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.02 [0.94-1.11],0.623244842280365,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLAT,Tissue-type plasminogen activator,Wald ratio,1,1.1 [0.75-1.6],0.626559238696222,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,24,0.99 [0.97-1.02],0.63502672758217,cis
Chapter IX Diseases of the circulatory system,I9_AF,THBS4,Thrombospondin-4,Inverse variance weighted,9,0.98 [0.88-1.08],0.635927731207496,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,1.09 [0.76-1.55],0.637467478299577,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRSS8,Prostasin,Inverse variance weighted,5,1.03 [0.9-1.18],0.645331159351445,cis
Chapter IX Diseases of the circulatory system,I9_AF,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,0.92 [0.64-1.32],0.650954904937524,cis
Chapter IX Diseases of the circulatory system,I9_AF,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.99 [0.97-1.02],0.652925885212681,cis
Chapter IX Diseases of the circulatory system,I9_AF,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,3,0.95 [0.78-1.17],0.654898501272267,cis
Chapter IX Diseases of the circulatory system,I9_AF,RETN,Resistin,Inverse variance weighted,9,1.01 [0.97-1.05],0.656539380755338,cis
Chapter IX Diseases of the circulatory system,I9_AF,MYOM3,Myomesin-3,Wald ratio,1,0.94 [0.73-1.22],0.659670269449063,cis
Chapter IX Diseases of the circulatory system,I9_AF,DKK4,Dickkopf-related protein 4,Inverse variance weighted,4,0.95 [0.74-1.21],0.660501618571359,cis
Chapter IX Diseases of the circulatory system,I9_AF,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,2,0.96 [0.79-1.16],0.662724596578457,cis
Chapter IX Diseases of the circulatory system,I9_AF,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.98 [0.92-1.06],0.665614745012004,cis
Chapter IX Diseases of the circulatory system,I9_AF,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,22,1.02 [0.95-1.09],0.666942258510585,cis
Chapter IX Diseases of the circulatory system,I9_AF,CAPG,Macrophage-capping protein,Inverse variance weighted,33,1.01 [0.97-1.05],0.669532888482336,cis
Chapter IX Diseases of the circulatory system,I9_AF,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,13,1.02 [0.92-1.13],0.675506944555281,cis
Chapter IX Diseases of the circulatory system,I9_AF,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,6,1.02 [0.94-1.11],0.676625087537274,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,14,0.99 [0.95-1.03],0.678911622895742,cis
Chapter IX Diseases of the circulatory system,I9_AF,GRN,Progranulin,Inverse variance weighted,7,1.01 [0.95-1.08],0.679274269060233,cis
Chapter IX Diseases of the circulatory system,I9_AF,KIF1C,Kinesin-like protein KIF1C,Wald ratio,1,1.13 [0.64-2],0.679772638226777,cis
Chapter IX Diseases of the circulatory system,I9_AF,MMP8,Neutrophil collagenase,Inverse variance weighted,17,0.99 [0.95-1.03],0.680720930444246,cis
Chapter IX Diseases of the circulatory system,I9_AF,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,2,1.02 [0.91-1.15],0.685815831819887,cis
Chapter IX Diseases of the circulatory system,I9_AF,F2,Prothrombin,Inverse variance weighted,6,1.02 [0.93-1.11],0.691596892588026,cis
Chapter IX Diseases of the circulatory system,I9_AF,HYAL1,Hyaluronidase-1,Inverse variance weighted,5,0.99 [0.92-1.06],0.692197258303252,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL19,Interleukin-19,Inverse variance weighted,11,0.99 [0.93-1.05],0.694771238658533,cis
Chapter IX Diseases of the circulatory system,I9_AF,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,3,0.98 [0.87-1.1],0.696155306690694,cis
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,10,0.99 [0.91-1.06],0.696298280995064,cis
Chapter IX Diseases of the circulatory system,I9_AF,SOD3,Extracellular superoxide dismutase,Inverse variance weighted,15,1.01 [0.97-1.04],0.697729324921478,cis
Chapter IX Diseases of the circulatory system,I9_AF,CDH1,Cadherin-1,Wald ratio,1,0.92 [0.61-1.4],0.700078215274665,cis
Chapter IX Diseases of the circulatory system,I9_AF,AREG,Amphiregulin,Inverse variance weighted,3,0.98 [0.86-1.11],0.701144400210463,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLK10,Kallikrein-10,Inverse variance weighted,15,1.01 [0.96-1.06],0.701569994735997,cis
Chapter IX Diseases of the circulatory system,I9_AF,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,2,0.97 [0.86-1.11],0.701588987391238,cis
Chapter IX Diseases of the circulatory system,I9_AF,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,1.03 [0.88-1.21],0.701720571788465,cis
Chapter IX Diseases of the circulatory system,I9_AF,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,1.01 [0.96-1.06],0.707030956078769,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.89 [0.49-1.61],0.707077117608298,cis
Chapter IX Diseases of the circulatory system,I9_AF,LGMN,Legumain,Inverse variance weighted,12,0.99 [0.92-1.06],0.708570260104906,cis
Chapter IX Diseases of the circulatory system,I9_AF,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,20,1.01 [0.98-1.04],0.708579372537817,cis
Chapter IX Diseases of the circulatory system,I9_AF,KRT18,"Keratin, type I cytoskeletal 18",Wald ratio,1,0.92 [0.61-1.4],0.709754334333462,cis
Chapter IX Diseases of the circulatory system,I9_AF,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,44,0.99 [0.97-1.02],0.713508092904857,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,1.01 [0.94-1.09],0.713562563811259,cis
Chapter IX Diseases of the circulatory system,I9_AF,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,4,0.98 [0.88-1.09],0.713930095123362,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,1.02 [0.92-1.13],0.714084394349995,cis
Chapter IX Diseases of the circulatory system,I9_AF,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.01 [0.94-1.09],0.71523625317337,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADIPOQ,Adiponectin,Inverse variance weighted,13,1.01 [0.95-1.08],0.716321881286675,cis
Chapter IX Diseases of the circulatory system,I9_AF,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,1.01 [0.94-1.09],0.716440313479629,cis
Chapter IX Diseases of the circulatory system,I9_AF,CDH2,Cadherin-2,Inverse variance weighted,3,1.04 [0.85-1.27],0.721779589987392,cis
Chapter IX Diseases of the circulatory system,I9_AF,CA14,Carbonic anhydrase 14,Inverse variance weighted,8,1.01 [0.97-1.05],0.727604041040218,cis
Chapter IX Diseases of the circulatory system,I9_AF,MYOC,Myocilin,Inverse variance weighted,21,0.99 [0.93-1.05],0.729129206969714,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.99 [0.94-1.04],0.729750363623035,cis
Chapter IX Diseases of the circulatory system,I9_AF,TFF3,Trefoil factor 3,Inverse variance weighted,5,0.98 [0.84-1.13],0.736522313988212,cis
Chapter IX Diseases of the circulatory system,I9_AF,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Wald ratio,1,1.04 [0.82-1.32],0.739204641747299,cis
Chapter IX Diseases of the circulatory system,I9_AF,AMBP,Protein AMBP,Inverse variance weighted,3,0.96 [0.74-1.23],0.739673562927512,cis
Chapter IX Diseases of the circulatory system,I9_AF,INHBB,Inhibin beta B chain,Inverse variance weighted,10,0.99 [0.93-1.05],0.740070046353937,cis
Chapter IX Diseases of the circulatory system,I9_AF,CYTL1,Cytokine-like protein 1,Inverse variance weighted,7,0.99 [0.96-1.03],0.741847467612607,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,3,0.98 [0.88-1.1],0.742910173865971,cis
Chapter IX Diseases of the circulatory system,I9_AF,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,25,1 [0.98-1.02],0.744300945257977,cis
Chapter IX Diseases of the circulatory system,I9_AF,CNTN4,Contactin-4,Inverse variance weighted,25,1.01 [0.97-1.05],0.744304088138934,cis
Chapter IX Diseases of the circulatory system,I9_AF,TTR,Transthyretin,Inverse variance weighted,3,0.96 [0.76-1.22],0.744866556256066,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL25,C-C motif chemokine 25,Inverse variance weighted,26,0.99 [0.95-1.04],0.745512512170239,cis
Chapter IX Diseases of the circulatory system,I9_AF,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.02 [0.9-1.16],0.745587759693319,cis
Chapter IX Diseases of the circulatory system,I9_AF,SLITRK1,SLIT and NTRK-like protein 1,Wald ratio,1,1.03 [0.86-1.24],0.745861464165871,cis
Chapter IX Diseases of the circulatory system,I9_AF,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,7,0.99 [0.95-1.04],0.747175980960287,cis
Chapter IX Diseases of the circulatory system,I9_AF,THBS2,Thrombospondin-2,Inverse variance weighted,16,0.99 [0.94-1.05],0.748474799801928,cis
Chapter IX Diseases of the circulatory system,I9_AF,MME,Neprilysin,Inverse variance weighted,3,1.09 [0.65-1.82],0.748948165706639,cis
Chapter IX Diseases of the circulatory system,I9_AF,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,2,1.04 [0.8-1.36],0.750562719811084,cis
Chapter IX Diseases of the circulatory system,I9_AF,APOL1,Apolipoprotein L1,Inverse variance weighted,3,1.02 [0.9-1.16],0.750621717218459,cis
Chapter IX Diseases of the circulatory system,I9_AF,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.02 [0.9-1.16],0.751048470630789,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL17C,Interleukin-17C,Inverse variance weighted,3,1.02 [0.89-1.18],0.753489533647152,cis
Chapter IX Diseases of the circulatory system,I9_AF,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,14,0.99 [0.93-1.05],0.753783539941465,cis
Chapter IX Diseases of the circulatory system,I9_AF,REG1B,Lithostathine-1-beta,Inverse variance weighted,18,1.01 [0.96-1.06],0.754252061517922,cis
Chapter IX Diseases of the circulatory system,I9_AF,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.99 [0.94-1.05],0.754906002580646,cis
Chapter IX Diseases of the circulatory system,I9_AF,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,1.01 [0.95-1.07],0.756019772385796,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLPS,Colipase,Inverse variance weighted,39,1.01 [0.97-1.04],0.756027435737575,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLIC5,Chloride intracellular channel protein 5,Inverse variance weighted,2,0.98 [0.84-1.13],0.756513478588311,cis
Chapter IX Diseases of the circulatory system,I9_AF,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,8,0.99 [0.91-1.07],0.756846175232439,cis
Chapter IX Diseases of the circulatory system,I9_AF,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.02 [0.9-1.16],0.760570418713894,cis
Chapter IX Diseases of the circulatory system,I9_AF,ALCAM,CD166 antigen,Inverse variance weighted,6,0.98 [0.87-1.11],0.761433419730904,cis
Chapter IX Diseases of the circulatory system,I9_AF,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,11,1.01 [0.95-1.08],0.762396788181722,cis
Chapter IX Diseases of the circulatory system,I9_AF,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,0.97 [0.77-1.21],0.763601924995827,cis
Chapter IX Diseases of the circulatory system,I9_AF,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,1 [0.98-1.03],0.763783791580594,cis
Chapter IX Diseases of the circulatory system,I9_AF,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.95 [0.69-1.31],0.764822523186437,cis
Chapter IX Diseases of the circulatory system,I9_AF,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,0.96 [0.75-1.23],0.765735244900046,cis
Chapter IX Diseases of the circulatory system,I9_AF,NRP2,Neuropilin-2,Inverse variance weighted,11,0.99 [0.92-1.06],0.766259896277884,cis
Chapter IX Diseases of the circulatory system,I9_AF,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,Inverse variance weighted,5,1.02 [0.88-1.18],0.766335714422551,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.01 [0.95-1.07],0.769561095772133,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Wald ratio,1,0.92 [0.54-1.59],0.774360763361187,cis
Chapter IX Diseases of the circulatory system,I9_AF,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.97 [0.79-1.2],0.778741913175431,cis
Chapter IX Diseases of the circulatory system,I9_AF,SEMA3F,Semaphorin-3F,Inverse variance weighted,15,0.98 [0.88-1.11],0.778796092208994,cis
Chapter IX Diseases of the circulatory system,I9_AF,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.98 [0.86-1.12],0.779261317415758,cis
Chapter IX Diseases of the circulatory system,I9_AF,NUCB2,Nucleobindin-2,Inverse variance weighted,24,1.01 [0.96-1.06],0.780428880230499,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,4,0.97 [0.78-1.21],0.782231158113474,cis
Chapter IX Diseases of the circulatory system,I9_AF,FCN1,Ficolin-1,Inverse variance weighted,28,0.99 [0.95-1.04],0.78433307039833,cis
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,23,0.99 [0.95-1.04],0.784838620852388,cis
Chapter IX Diseases of the circulatory system,I9_AF,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,20,0.99 [0.95-1.04],0.786380459910325,cis
Chapter IX Diseases of the circulatory system,I9_AF,ROBO2,Roundabout homolog 2,Inverse variance weighted,2,1.04 [0.78-1.39],0.78763321689759,cis
Chapter IX Diseases of the circulatory system,I9_AF,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.01 [0.94-1.08],0.78773003498822,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCN4,CCN family member 4,Inverse variance weighted,27,1 [0.96-1.03],0.788811255855895,cis
Chapter IX Diseases of the circulatory system,I9_AF,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,17,0.99 [0.94-1.05],0.791115840540328,cis
Chapter IX Diseases of the circulatory system,I9_AF,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,31,1 [0.97-1.04],0.795756990528542,cis
Chapter IX Diseases of the circulatory system,I9_AF,PRTG,Protogenin,Inverse variance weighted,19,1 [0.97-1.04],0.796796811508058,cis
Chapter IX Diseases of the circulatory system,I9_AF,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,6,0.99 [0.89-1.09],0.797618057869697,cis
Chapter IX Diseases of the circulatory system,I9_AF,GPR15L,Protein GPR15L,Inverse variance weighted,9,0.99 [0.93-1.06],0.798212126595894,cis
Chapter IX Diseases of the circulatory system,I9_AF,PCDHB15,Protocadherin beta-15,Inverse variance weighted,29,1.01 [0.96-1.05],0.801572559225968,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.99 [0.89-1.09],0.80347365088558,cis
Chapter IX Diseases of the circulatory system,I9_AF,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,6,1.02 [0.88-1.18],0.804304753984908,cis
Chapter IX Diseases of the circulatory system,I9_AF,MVK,Mevalonate kinase,Inverse variance weighted,2,0.97 [0.79-1.2],0.806229952247238,cis
Chapter IX Diseases of the circulatory system,I9_AF,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.01 [0.94-1.08],0.80649259537036,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.99 [0.92-1.07],0.80739912426662,cis
Chapter IX Diseases of the circulatory system,I9_AF,DRAXIN,Draxin,Inverse variance weighted,13,0.99 [0.95-1.04],0.809525780853479,cis
Chapter IX Diseases of the circulatory system,I9_AF,CHGA,Chromogranin-A,Inverse variance weighted,3,0.99 [0.88-1.11],0.809656132402081,cis
Chapter IX Diseases of the circulatory system,I9_AF,CX3CL1,Fractalkine,Inverse variance weighted,9,1.01 [0.92-1.11],0.813436118845828,cis
Chapter IX Diseases of the circulatory system,I9_AF,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.98 [0.83-1.16],0.814460346086472,cis
Chapter IX Diseases of the circulatory system,I9_AF,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.04 [0.75-1.43],0.819186244469648,cis
Chapter IX Diseases of the circulatory system,I9_AF,CNTN3,Contactin-3,Inverse variance weighted,14,0.99 [0.94-1.05],0.823844969236089,cis
Chapter IX Diseases of the circulatory system,I9_AF,PROC,Vitamin K-dependent protein C,Inverse variance weighted,4,1.03 [0.8-1.32],0.827462260392883,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD248,Endosialin,Inverse variance weighted,2,0.9 [0.34-2.37],0.827851753451037,cis
Chapter IX Diseases of the circulatory system,I9_AF,KLK4,Kallikrein-4,Inverse variance weighted,17,1 [0.95-1.04],0.828044686272922,cis
Chapter IX Diseases of the circulatory system,I9_AF,APOA1,Apolipoprotein A-I,Inverse variance weighted,2,1.07 [0.57-2.02],0.832899826292137,cis
Chapter IX Diseases of the circulatory system,I9_AF,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1 [0.97-1.03],0.836018212205992,cis
Chapter IX Diseases of the circulatory system,I9_AF,FAM3C,Protein FAM3C,Inverse variance weighted,2,0.97 [0.69-1.35],0.837359850452075,cis
Chapter IX Diseases of the circulatory system,I9_AF,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.03 [0.79-1.35],0.837719329342122,cis
Chapter IX Diseases of the circulatory system,I9_AF,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.01 [0.88-1.17],0.841383322489288,cis
Chapter IX Diseases of the circulatory system,I9_AF,CALB1,Calbindin,Inverse variance weighted,2,1.02 [0.82-1.28],0.842445512017607,cis
Chapter IX Diseases of the circulatory system,I9_AF,COL3A1,Collagen alpha-1(III) chain,Wald ratio,1,0.95 [0.59-1.53],0.84396450078658,cis
Chapter IX Diseases of the circulatory system,I9_AF,AGRN,Agrin,Inverse variance weighted,17,0.99 [0.93-1.06],0.8505364924889,cis
Chapter IX Diseases of the circulatory system,I9_AF,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,1.01 [0.93-1.09],0.853166394412749,cis
Chapter IX Diseases of the circulatory system,I9_AF,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,4,1.01 [0.91-1.12],0.855132003561319,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD276,CD276 antigen,Inverse variance weighted,20,1 [0.96-1.05],0.85704995205196,cis
Chapter IX Diseases of the circulatory system,I9_AF,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,6,1 [0.97-1.03],0.858932071305612,cis
Chapter IX Diseases of the circulatory system,I9_AF,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,6,0.99 [0.94-1.05],0.859540289227226,cis
Chapter IX Diseases of the circulatory system,I9_AF,DSG2,Desmoglein-2,Inverse variance weighted,11,0.99 [0.93-1.06],0.861666654304987,cis
Chapter IX Diseases of the circulatory system,I9_AF,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,37,1 [0.96-1.05],0.86353605915174,cis
Chapter IX Diseases of the circulatory system,I9_AF,LAYN,Layilin,Inverse variance weighted,20,1 [0.95-1.06],0.869309235718141,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,11,1 [0.97-1.02],0.869481515057888,cis
Chapter IX Diseases of the circulatory system,I9_AF,MB,Myoglobin,Wald ratio,1,0.96 [0.57-1.61],0.870686359573569,cis
Chapter IX Diseases of the circulatory system,I9_AF,FGA,Fibrinogen alpha chain,Inverse variance weighted,7,1.01 [0.9-1.13],0.875134640514362,cis
Chapter IX Diseases of the circulatory system,I9_AF,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,7,1.01 [0.93-1.09],0.875420561975484,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.98 [0.8-1.21],0.875695261888612,cis
Chapter IX Diseases of the circulatory system,I9_AF,POSTN,Periostin,Inverse variance weighted,10,1.01 [0.94-1.07],0.876140788937406,cis
Chapter IX Diseases of the circulatory system,I9_AF,F3,Tissue factor,Inverse variance weighted,11,0.99 [0.93-1.07],0.878507224417733,cis
Chapter IX Diseases of the circulatory system,I9_AF,CTSV,Cathepsin L2,Inverse variance weighted,11,1.01 [0.93-1.09],0.878736996568867,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,1 [0.94-1.05],0.88047927818919,cis
Chapter IX Diseases of the circulatory system,I9_AF,MENT,Protein MENT,Inverse variance weighted,3,1 [0.96-1.04],0.884775780952128,cis
Chapter IX Diseases of the circulatory system,I9_AF,BSG,Basigin,Wald ratio,1,0.99 [0.86-1.14],0.885051966065118,cis
Chapter IX Diseases of the circulatory system,I9_AF,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.02 [0.79-1.31],0.885796998702291,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP1,Insulin-like growth factor-binding protein 1,Wald ratio,1,1.03 [0.67-1.59],0.887313016900748,cis
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,14,1 [0.96-1.03],0.889824128455331,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,3,0.98 [0.74-1.29],0.890007923520849,cis
Chapter IX Diseases of the circulatory system,I9_AF,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,1.01 [0.91-1.11],0.892093927186825,cis
Chapter IX Diseases of the circulatory system,I9_AF,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,34,1 [0.98-1.03],0.896902052049477,cis
Chapter IX Diseases of the circulatory system,I9_AF,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,18,1 [0.97-1.04],0.897600505444553,cis
Chapter IX Diseases of the circulatory system,I9_AF,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,3,1.01 [0.84-1.23],0.897889431379713,cis
Chapter IX Diseases of the circulatory system,I9_AF,TCN2,Transcobalamin-2,Inverse variance weighted,34,1 [0.97-1.04],0.899502430819897,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPP1,Osteopontin,Inverse variance weighted,8,1.01 [0.85-1.2],0.899644085387211,cis
Chapter IX Diseases of the circulatory system,I9_AF,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,8,1.01 [0.92-1.1],0.899984709986484,cis
Chapter IX Diseases of the circulatory system,I9_AF,ANG,Angiogenin,Inverse variance weighted,19,1 [0.96-1.04],0.90099835291091,cis
Chapter IX Diseases of the circulatory system,I9_AF,LEPR,Leptin receptor,Inverse variance weighted,8,1 [0.93-1.08],0.901894341603981,cis
Chapter IX Diseases of the circulatory system,I9_AF,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,1 [0.93-1.08],0.903588272761272,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,3,0.99 [0.79-1.23],0.905290713216275,cis
Chapter IX Diseases of the circulatory system,I9_AF,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,1 [0.93-1.08],0.907572291329404,cis
Chapter IX Diseases of the circulatory system,I9_AF,BCAM,Basal cell adhesion molecule,Inverse variance weighted,12,0.99 [0.89-1.11],0.913208453340582,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,29,1 [0.97-1.03],0.913455949610662,cis
Chapter IX Diseases of the circulatory system,I9_AF,FABP6,Gastrotropin,Wald ratio,1,1.01 [0.87-1.17],0.913494522639405,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,5,0.99 [0.86-1.14],0.914130231993222,cis
Chapter IX Diseases of the circulatory system,I9_AF,TFRC,Transferrin receptor protein 1,Inverse variance weighted,28,1 [0.95-1.05],0.916785983041965,cis
Chapter IX Diseases of the circulatory system,I9_AF,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,0.99 [0.9-1.1],0.91690290076499,cis
Chapter IX Diseases of the circulatory system,I9_AF,SERPIND1,Heparin cofactor 2,Wald ratio,1,0.99 [0.79-1.24],0.918893659893372,cis
Chapter IX Diseases of the circulatory system,I9_AF,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,0.97 [0.57-1.65],0.919074515258452,cis
Chapter IX Diseases of the circulatory system,I9_AF,MDK,Midkine,Inverse variance weighted,4,0.99 [0.87-1.13],0.91990154078084,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,24,1 [0.96-1.04],0.923176065666981,cis
Chapter IX Diseases of the circulatory system,I9_AF,NTF3,Neurotrophin-3,Inverse variance weighted,8,1 [0.92-1.08],0.924168628848058,cis
Chapter IX Diseases of the circulatory system,I9_AF,PENK,Proenkephalin-A,Inverse variance weighted,19,1 [0.95-1.05],0.925225402113134,cis
Chapter IX Diseases of the circulatory system,I9_AF,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,12,1 [0.93-1.07],0.927942731953634,cis
Chapter IX Diseases of the circulatory system,I9_AF,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,8,1 [0.93-1.09],0.932700986938438,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.01 [0.75-1.38],0.9328610673234,cis
Chapter IX Diseases of the circulatory system,I9_AF,DDC,Aromatic-L-amino-acid decarboxylase,Inverse variance weighted,10,1 [0.95-1.05],0.9352841005726,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNC,Tenascin,Inverse variance weighted,12,1 [0.92-1.08],0.939976607372717,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,5,1 [0.89-1.14],0.941058690860404,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1 [0.97-1.04],0.94213928312637,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,1 [0.93-1.06],0.942422681081576,cis
Chapter IX Diseases of the circulatory system,I9_AF,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,8,1 [0.91-1.09],0.947932376453521,cis
Chapter IX Diseases of the circulatory system,I9_AF,DPT,Dermatopontin,Inverse variance weighted,21,1 [0.95-1.05],0.948045646717899,cis
Chapter IX Diseases of the circulatory system,I9_AF,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1 [0.88-1.15],0.949059204086653,cis
Chapter IX Diseases of the circulatory system,I9_AF,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,1.01 [0.71-1.43],0.94973097396133,cis
Chapter IX Diseases of the circulatory system,I9_AF,CTSD,Cathepsin D,Inverse variance weighted,17,1 [0.94-1.06],0.952306972304218,cis
Chapter IX Diseases of the circulatory system,I9_AF,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,10,1 [0.92-1.08],0.958550424531429,cis
Chapter IX Diseases of the circulatory system,I9_AF,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.99 [0.69-1.42],0.960375063978618,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1 [0.94-1.07],0.960621267358934,cis
Chapter IX Diseases of the circulatory system,I9_AF,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,2,0.99 [0.76-1.3],0.962657279507003,cis
Chapter IX Diseases of the circulatory system,I9_AF,SERPINA11,Serpin A11,Inverse variance weighted,31,1 [0.97-1.03],0.965040316204198,cis
Chapter IX Diseases of the circulatory system,I9_AF,LGALS9,Galectin-9,Inverse variance weighted,26,1 [0.96-1.04],0.965350511658584,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1 [0.88-1.15],0.967530610985152,cis
Chapter IX Diseases of the circulatory system,I9_AF,MPO,Myeloperoxidase,Inverse variance weighted,11,1 [0.95-1.05],0.971874366797544,cis
Chapter IX Diseases of the circulatory system,I9_AF,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,7,1 [0.93-1.07],0.97629683705598,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1 [0.96-1.04],0.977610459959843,cis
Chapter IX Diseases of the circulatory system,I9_AF,CCL20,C-C motif chemokine 20,Inverse variance weighted,2,1 [0.8-1.25],0.982734976510364,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1 [0.92-1.09],0.983449575874963,cis
Chapter IX Diseases of the circulatory system,I9_AF,ELN,Elastin,Inverse variance weighted,2,1.01 [0.57-1.79],0.984079526397086,cis
Chapter IX Diseases of the circulatory system,I9_AF,NPPC,C-type natriuretic peptide,Wald ratio,1,1 [0.63-1.6],0.984343753849186,cis
Chapter IX Diseases of the circulatory system,I9_AF,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,Wald ratio,1,1 [0.72-1.41],0.98450138070123,cis
Chapter IX Diseases of the circulatory system,I9_AF,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,49,1 [0.98-1.02],0.985016904479811,cis
Chapter IX Diseases of the circulatory system,I9_AF,CA6,Carbonic anhydrase 6,Inverse variance weighted,31,1 [0.96-1.04],0.985865328519816,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1 [0.96-1.04],0.986641950293381,cis
Chapter IX Diseases of the circulatory system,I9_AF,SHISA5,Protein shisa-5,Inverse variance weighted,5,1 [0.82-1.21],0.987776553212457,cis
Chapter IX Diseases of the circulatory system,I9_AF,FBLN2,Fibulin-2,Inverse variance weighted,11,1 [0.95-1.05],0.988281709624645,cis
Chapter IX Diseases of the circulatory system,I9_AF,SERPINB8,Serpin B8,Inverse variance weighted,28,1 [0.98-1.02],0.9911054698089,cis
Chapter IX Diseases of the circulatory system,I9_AF,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,1 [0.96-1.05],0.99319195293079,cis
Chapter IX Diseases of the circulatory system,I9_AF,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,21,1 [0.96-1.05],0.995431867418946,cis
Chapter IX Diseases of the circulatory system,I9_AF,TSPAN8,Tetraspanin-8,Inverse variance weighted,25,1 [0.95-1.05],0.997803326461886,cis
Chapter IX Diseases of the circulatory system,I9_AF,CXCL13,C-X-C motif chemokine 13,Wald ratio,1,3.72 [2.42-5.71],1.92217662273644e-09,trans
Chapter IX Diseases of the circulatory system,I9_AF,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,Inverse variance weighted,43,1.07 [1.04-1.1],7.79749713637155e-06,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL22,Interleukin-22,Inverse variance weighted,4,0.57 [0.44-0.74],3.97301339630374e-05,trans
Chapter IX Diseases of the circulatory system,I9_AF,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,1.16 [1.07-1.25],0.000258582259647392,trans
Chapter IX Diseases of the circulatory system,I9_AF,VEGFB,Vascular endothelial growth factor B,Inverse variance weighted,7,0.76 [0.65-0.88],0.00035473318442656,trans
Chapter IX Diseases of the circulatory system,I9_AF,LAYN,Layilin,Inverse variance weighted,3,1.62 [1.24-2.11],0.000431230898491949,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G2A,"Phospholipase A2, membrane associated",Inverse variance weighted,3,0.7 [0.57-0.86],0.000843587049991542,trans
Chapter IX Diseases of the circulatory system,I9_AF,NOS1,"Nitric oxide synthase, brain",Wald ratio,1,1.72 [1.25-2.36],0.000845807420426598,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLK10,Kallikrein-10,Wald ratio,1,0.42 [0.25-0.7],0.000916807629715309,trans
Chapter IX Diseases of the circulatory system,I9_AF,SDC1,Syndecan-1,Inverse variance weighted,12,1.2 [1.07-1.34],0.00125623517864142,trans
Chapter IX Diseases of the circulatory system,I9_AF,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",Inverse variance weighted,7,1.19 [1.07-1.33],0.00166765524933954,trans
Chapter IX Diseases of the circulatory system,I9_AF,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.68 [0.53-0.87],0.0018835951678697,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.67 [0.52-0.86],0.00193963889929961,trans
Chapter IX Diseases of the circulatory system,I9_AF,MUC13,Mucin-13,Inverse variance weighted,3,0.66 [0.51-0.86],0.00214792370370297,trans
Chapter IX Diseases of the circulatory system,I9_AF,F2,Prothrombin,Inverse variance weighted,18,1.15 [1.05-1.26],0.00216295550714409,trans
Chapter IX Diseases of the circulatory system,I9_AF,PROC,Vitamin K-dependent protein C,Inverse variance weighted,40,0.96 [0.94-0.99],0.00222646697917645,trans
Chapter IX Diseases of the circulatory system,I9_AF,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,0.76 [0.64-0.91],0.00230293125773001,trans
Chapter IX Diseases of the circulatory system,I9_AF,OCLN,Occludin,Inverse variance weighted,2,1.53 [1.16-2.02],0.00240865464038386,trans
Chapter IX Diseases of the circulatory system,I9_AF,SLURP1,Secreted Ly-6/uPAR-related protein 1,Inverse variance weighted,19,0.93 [0.89-0.97],0.00252029943355476,trans
Chapter IX Diseases of the circulatory system,I9_AF,LMOD1,Leiomodin-1,Inverse variance weighted,6,0.83 [0.73-0.94],0.0026946380252187,trans
Chapter IX Diseases of the circulatory system,I9_AF,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,1.19 [1.06-1.33],0.00275169202382749,trans
Chapter IX Diseases of the circulatory system,I9_AF,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.42 [0.24-0.74],0.00279826559303686,trans
Chapter IX Diseases of the circulatory system,I9_AF,F7,Coagulation factor VII,Inverse variance weighted,10,0.84 [0.75-0.95],0.00518756152450091,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.2 [1.05-1.35],0.00520779381586365,trans
Chapter IX Diseases of the circulatory system,I9_AF,CA14,Carbonic anhydrase 14,Inverse variance weighted,11,0.83 [0.73-0.95],0.00566868474897982,trans
Chapter IX Diseases of the circulatory system,I9_AF,LMNB1,Lamin-B1,Inverse variance weighted,3,0.8 [0.68-0.94],0.0066334975013241,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL15A1,Collagen alpha-1(XV) chain,Inverse variance weighted,10,1.15 [1.04-1.26],0.00701871431367665,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,0.95 [0.91-0.99],0.0075667767396608,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGF5,Fibroblast growth factor 5,Inverse variance weighted,18,1.13 [1.03-1.23],0.00786604544946159,trans
Chapter IX Diseases of the circulatory system,I9_AF,CSTB,Cystatin-B,Inverse variance weighted,23,1.05 [1.01-1.1],0.0100794295340588,trans
Chapter IX Diseases of the circulatory system,I9_AF,AHNAK,Neuroblast differentiation-associated protein AHNAK,Inverse variance weighted,3,0.72 [0.56-0.92],0.0103095420584032,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC3B,Tetranectin,Inverse variance weighted,2,1.58 [1.11-2.25],0.0104722033608867,trans
Chapter IX Diseases of the circulatory system,I9_AF,VWC2,Brorin,Inverse variance weighted,12,1.19 [1.04-1.36],0.010981184838078,trans
Chapter IX Diseases of the circulatory system,I9_AF,FCRLB,Fc receptor-like B,Inverse variance weighted,10,0.84 [0.73-0.96],0.0116440825768208,trans
Chapter IX Diseases of the circulatory system,I9_AF,NCAM2,Neural cell adhesion molecule 2,Inverse variance weighted,39,0.96 [0.93-0.99],0.0118291086216929,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,1.69 [1.12-2.54],0.0122202577845094,trans
Chapter IX Diseases of the circulatory system,I9_AF,MYOC,Myocilin,Inverse variance weighted,12,0.86 [0.76-0.97],0.0123967481903761,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.36 [1.07-1.73],0.0128972376288974,trans
Chapter IX Diseases of the circulatory system,I9_AF,TFRC,Transferrin receptor protein 1,Inverse variance weighted,19,1.11 [1.02-1.21],0.0150669859938012,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL6,Interleukin-6,Inverse variance weighted,6,0.89 [0.81-0.98],0.0156854601228018,trans
Chapter IX Diseases of the circulatory system,I9_AF,SMPD1,Sphingomyelin phosphodiesterase,Inverse variance weighted,20,1.07 [1.01-1.13],0.0159740963004816,trans
Chapter IX Diseases of the circulatory system,I9_AF,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,Inverse variance weighted,5,1.22 [1.04-1.44],0.0168352787590796,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD300A,CMRF35-like molecule 8,Inverse variance weighted,35,1.05 [1.01-1.09],0.0177173493934291,trans
Chapter IX Diseases of the circulatory system,I9_AF,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.76 [0.6-0.96],0.0207148896698954,trans
Chapter IX Diseases of the circulatory system,I9_AF,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,0.55 [0.32-0.92],0.0218520186128006,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLSTN2,Calsyntenin-2,Inverse variance weighted,8,0.84 [0.73-0.98],0.0222481765696758,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRTN3,Myeloblastin,Inverse variance weighted,20,1.1 [1.01-1.19],0.0226439817515292,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACE,Angiotensin-converting enzyme,Inverse variance weighted,27,1.07 [1.01-1.14],0.0240613872696754,trans
Chapter IX Diseases of the circulatory system,I9_AF,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,1.13 [1.02-1.25],0.0242301754590696,trans
Chapter IX Diseases of the circulatory system,I9_AF,ATRN,"Attractin, Isoform 2",Inverse variance weighted,8,0.83 [0.7-0.98],0.0252050500407078,trans
Chapter IX Diseases of the circulatory system,I9_AF,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",Inverse variance weighted,29,1.14 [1.02-1.27],0.025660744623406,trans
Chapter IX Diseases of the circulatory system,I9_AF,TMEM25,Transmembrane protein 25,Wald ratio,1,0.67 [0.47-0.96],0.0282893166768148,trans
Chapter IX Diseases of the circulatory system,I9_AF,PALM2,Paralemmin-2,Inverse variance weighted,9,1.1 [1.01-1.19],0.0287791657783187,trans
Chapter IX Diseases of the circulatory system,I9_AF,LEPR,Leptin receptor,Inverse variance weighted,3,1.29 [1.03-1.62],0.0290262692220185,trans
Chapter IX Diseases of the circulatory system,I9_AF,RNASE10,Inactive ribonuclease-like protein 10,Wald ratio,1,1.77 [1.06-2.97],0.0292234612777522,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCN3,CCN family member 3,Inverse variance weighted,17,1.1 [1.01-1.2],0.031200847732173,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,1.11 [1.01-1.22],0.0334136506139635,trans
Chapter IX Diseases of the circulatory system,I9_AF,AGRP,Agouti-related protein,Inverse variance weighted,16,1.15 [1.01-1.3],0.0342653759816529,trans
Chapter IX Diseases of the circulatory system,I9_AF,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.86 [0.74-0.99],0.0343603187490882,trans
Chapter IX Diseases of the circulatory system,I9_AF,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",Wald ratio,1,1.47 [1.03-2.11],0.0354289330467789,trans
Chapter IX Diseases of the circulatory system,I9_AF,FAM20A,Pseudokinase FAM20A,Inverse variance weighted,21,1.05 [1-1.1],0.0356002834228791,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,Inverse variance weighted,8,0.73 [0.54-0.98],0.0357116994440317,trans
Chapter IX Diseases of the circulatory system,I9_AF,MMP8,Neutrophil collagenase,Inverse variance weighted,10,1.13 [1.01-1.27],0.0357210048742362,trans
Chapter IX Diseases of the circulatory system,I9_AF,CKB,Creatine kinase B-type,Inverse variance weighted,11,0.84 [0.71-0.99],0.0362404617339397,trans
Chapter IX Diseases of the circulatory system,I9_AF,FAM3C,Protein FAM3C,Inverse variance weighted,3,1.41 [1.02-1.94],0.036454599907652,trans
Chapter IX Diseases of the circulatory system,I9_AF,FAP,Prolyl endopeptidase FAP,Inverse variance weighted,9,1.12 [1-1.24],0.0421108371598896,trans
Chapter IX Diseases of the circulatory system,I9_AF,MYOM2,Myomesin-2,Wald ratio,1,1.36 [1.01-1.83],0.0423340242047509,trans
Chapter IX Diseases of the circulatory system,I9_AF,VMO1,Vitelline membrane outer layer protein 1 homolog,Inverse variance weighted,8,1.18 [1-1.4],0.04517914000526,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,1.23 [1-1.5],0.0453088479894149,trans
Chapter IX Diseases of the circulatory system,I9_AF,MATN2,Matrilin-2,Inverse variance weighted,28,1.04 [1-1.08],0.0456122256640628,trans
Chapter IX Diseases of the circulatory system,I9_AF,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,Inverse variance weighted,17,1.09 [1-1.19],0.047426560621625,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,0.9 [0.8-1],0.0499216634763525,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRCP,Lysosomal Pro-X carboxypeptidase,Inverse variance weighted,22,1.09 [1-1.2],0.0531223351669663,trans
Chapter IX Diseases of the circulatory system,I9_AF,CSPG4,Chondroitin sulfate proteoglycan 4,Inverse variance weighted,12,1.18 [1-1.41],0.0541242701379849,trans
Chapter IX Diseases of the circulatory system,I9_AF,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.26 [1-1.58],0.0541780488933837,trans
Chapter IX Diseases of the circulatory system,I9_AF,MDK,Midkine,Inverse variance weighted,14,0.9 [0.8-1],0.0543889715758589,trans
Chapter IX Diseases of the circulatory system,I9_AF,NME3,Nucleoside diphosphate kinase 3,Inverse variance weighted,11,0.91 [0.83-1],0.0545884815369825,trans
Chapter IX Diseases of the circulatory system,I9_AF,HYAL1,Hyaluronidase-1,Inverse variance weighted,19,1.06 [1-1.12],0.0549193328705221,trans
Chapter IX Diseases of the circulatory system,I9_AF,CPXM2,Inactive carboxypeptidase-like protein X2,Inverse variance weighted,26,1.05 [1-1.1],0.0563715665220906,trans
Chapter IX Diseases of the circulatory system,I9_AF,LDLR,Low-density lipoprotein receptor,Inverse variance weighted,17,1.11 [1-1.23],0.0566656941152503,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCT,Secretin,Inverse variance weighted,5,1.27 [0.99-1.62],0.0575581854610909,trans
Chapter IX Diseases of the circulatory system,I9_AF,APCS,Serum amyloid P-component,Inverse variance weighted,3,1.26 [0.99-1.6],0.0591295360880076,trans
Chapter IX Diseases of the circulatory system,I9_AF,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.26 [0.99-1.61],0.0595134547901514,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRSS2,Trypsin-2,Inverse variance weighted,17,0.92 [0.85-1],0.0602154496323218,trans
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC8,Sialic acid-binding Ig-like lectin 8,Inverse variance weighted,21,1.09 [1-1.19],0.0612978527336038,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.83 [0.68-1.01],0.0615792682441528,trans
Chapter IX Diseases of the circulatory system,I9_AF,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,Wald ratio,1,1.33 [0.99-1.79],0.0621658132390405,trans
Chapter IX Diseases of the circulatory system,I9_AF,WFDC12,WAP four-disulfide core domain protein 12,Inverse variance weighted,56,0.96 [0.93-1],0.0622961464283738,trans
Chapter IX Diseases of the circulatory system,I9_AF,DCN,Decorin,Inverse variance weighted,2,0.72 [0.52-1.02],0.0626381099669308,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXCL11,C-X-C motif chemokine 11,Inverse variance weighted,11,1.11 [0.99-1.23],0.0630285246640911,trans
Chapter IX Diseases of the circulatory system,I9_AF,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.32 [0.98-1.78],0.0633132402439711,trans
Chapter IX Diseases of the circulatory system,I9_AF,DPT,Dermatopontin,Inverse variance weighted,4,1.25 [0.99-1.58],0.0655210543662061,trans
Chapter IX Diseases of the circulatory system,I9_AF,RNASE4,Ribonuclease 4,Inverse variance weighted,2,0.62 [0.37-1.03],0.0657994342833257,trans
Chapter IX Diseases of the circulatory system,I9_AF,ENG,Endoglin,Inverse variance weighted,18,0.96 [0.91-1],0.0663127123291698,trans
Chapter IX Diseases of the circulatory system,I9_AF,LEP,Leptin,Inverse variance weighted,4,2.15 [0.95-4.87],0.0663267105042631,trans
Chapter IX Diseases of the circulatory system,I9_AF,AOC3,Membrane primary amine oxidase,Inverse variance weighted,34,1.03 [1-1.07],0.0691787987831959,trans
Chapter IX Diseases of the circulatory system,I9_AF,BCAM,Basal cell adhesion molecule,Inverse variance weighted,22,0.96 [0.92-1],0.0766914214886643,trans
Chapter IX Diseases of the circulatory system,I9_AF,BMP4,Bone morphogenetic protein 4,Inverse variance weighted,5,0.82 [0.65-1.02],0.0768322487990838,trans
Chapter IX Diseases of the circulatory system,I9_AF,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,Inverse variance weighted,37,0.94 [0.88-1.01],0.0784920255307542,trans
Chapter IX Diseases of the circulatory system,I9_AF,MME,Neprilysin,Inverse variance weighted,46,1.05 [0.99-1.11],0.0788030304385324,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,0.85 [0.7-1.02],0.0793316557261207,trans
Chapter IX Diseases of the circulatory system,I9_AF,GAST,Gastrin,Inverse variance weighted,9,0.87 [0.75-1.02],0.0796813724672772,trans
Chapter IX Diseases of the circulatory system,I9_AF,MAMDC2,MAM domain-containing protein 2,Inverse variance weighted,22,1.05 [0.99-1.12],0.0810201600033486,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.68 [0.43-1.05],0.0824100636407704,trans
Chapter IX Diseases of the circulatory system,I9_AF,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.63 [0.94-2.82],0.083608282081052,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD7,T-cell antigen CD7,Inverse variance weighted,12,0.97 [0.93-1],0.0836700015786543,trans
Chapter IX Diseases of the circulatory system,I9_AF,GPNMB,Transmembrane glycoprotein NMB,Inverse variance weighted,5,1.05 [0.99-1.12],0.0842885437145828,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.12 [0.98-1.29],0.0871992105474825,trans
Chapter IX Diseases of the circulatory system,I9_AF,NOS3,"Nitric oxide synthase, endothelial",Inverse variance weighted,5,0.8 [0.61-1.03],0.0872619380185344,trans
Chapter IX Diseases of the circulatory system,I9_AF,NT5E,5'-nucleotidase,Inverse variance weighted,45,0.97 [0.93-1.01],0.0874113734288216,trans
Chapter IX Diseases of the circulatory system,I9_AF,SEPTIN8,Septin-8,Inverse variance weighted,4,1.17 [0.98-1.39],0.089108546820578,trans
Chapter IX Diseases of the circulatory system,I9_AF,DCTPP1,dCTP pyrophosphatase 1,Inverse variance weighted,5,1.22 [0.97-1.55],0.0891739880020781,trans
Chapter IX Diseases of the circulatory system,I9_AF,SFTPA2,Pulmonary surfactant-associated protein A2,Inverse variance weighted,27,1.03 [1-1.07],0.0892158613717516,trans
Chapter IX Diseases of the circulatory system,I9_AF,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,Inverse variance weighted,6,0.87 [0.74-1.02],0.0898582481943032,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD276,CD276 antigen,Inverse variance weighted,24,0.94 [0.88-1.01],0.0900414860819737,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,Inverse variance weighted,13,0.9 [0.8-1.02],0.0910603164142025,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXCL16,C-X-C motif chemokine 16,Inverse variance weighted,15,0.91 [0.82-1.02],0.0925084774077443,trans
Chapter IX Diseases of the circulatory system,I9_AF,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,Inverse variance weighted,14,1.18 [0.97-1.42],0.0934584121410719,trans
Chapter IX Diseases of the circulatory system,I9_AF,MMP7,Matrilysin,Wald ratio,1,0.86 [0.72-1.03],0.0949960239462486,trans
Chapter IX Diseases of the circulatory system,I9_AF,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1.11 [0.98-1.24],0.0965585092714531,trans
Chapter IX Diseases of the circulatory system,I9_AF,OGN,Mimecan,Inverse variance weighted,37,0.96 [0.92-1.01],0.0971055685497319,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,0.92 [0.83-1.02],0.0982316331442457,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF8,Tumor necrosis factor ligand superfamily member 8,Inverse variance weighted,15,0.93 [0.86-1.01],0.0985180501809486,trans
Chapter IX Diseases of the circulatory system,I9_AF,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,1.15 [0.97-1.37],0.0988864643689459,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNN,Tenascin-N,Inverse variance weighted,41,1.03 [0.99-1.07],0.0990130143072258,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPINK2,Serine protease inhibitor Kazal-type 2,Inverse variance weighted,17,0.91 [0.81-1.02],0.0991382619436222,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL23,C-C motif chemokine 23,Inverse variance weighted,23,1.03 [0.99-1.07],0.0993888852577769,trans
Chapter IX Diseases of the circulatory system,I9_AF,C7,Complement component C7,Inverse variance weighted,26,1.04 [0.99-1.08],0.101387433742039,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGF1R,Insulin-like growth factor 1 receptor,Inverse variance weighted,6,1.23 [0.96-1.57],0.101479093243636,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGSF8,Immunoglobulin superfamily member 8,Inverse variance weighted,4,1.14 [0.97-1.32],0.102656994045763,trans
Chapter IX Diseases of the circulatory system,I9_AF,DRAXIN,Draxin,Inverse variance weighted,25,1.08 [0.98-1.17],0.105232633114672,trans
Chapter IX Diseases of the circulatory system,I9_AF,TXNDC15,Thioredoxin domain-containing protein 15,Inverse variance weighted,28,1.03 [0.99-1.08],0.105283034844571,trans
Chapter IX Diseases of the circulatory system,I9_AF,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,1.11 [0.98-1.26],0.106203844969814,trans
Chapter IX Diseases of the circulatory system,I9_AF,TPMT,Thiopurine S-methyltransferase,Inverse variance weighted,7,1.18 [0.97-1.43],0.106744024613888,trans
Chapter IX Diseases of the circulatory system,I9_AF,MSLN,Mesothelin,Inverse variance weighted,11,1.18 [0.96-1.45],0.108014241503803,trans
Chapter IX Diseases of the circulatory system,I9_AF,TFPI,Tissue factor pathway inhibitor,Inverse variance weighted,20,1.06 [0.99-1.15],0.108126700618933,trans
Chapter IX Diseases of the circulatory system,I9_AF,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,1.11 [0.98-1.26],0.109440556265925,trans
Chapter IX Diseases of the circulatory system,I9_AF,PSAP,Prosaposin,Inverse variance weighted,13,1.05 [0.99-1.12],0.110199828227504,trans
Chapter IX Diseases of the circulatory system,I9_AF,NXPH3,Neurexophilin-3,Inverse variance weighted,19,1.05 [0.99-1.13],0.110758133696291,trans
Chapter IX Diseases of the circulatory system,I9_AF,BRK1,Protein BRICK1,Inverse variance weighted,10,0.93 [0.86-1.02],0.111238670442885,trans
Chapter IX Diseases of the circulatory system,I9_AF,PTN,Pleiotrophin,Inverse variance weighted,3,0.84 [0.68-1.04],0.111406284255744,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACHE,Acetylcholinesterase,Inverse variance weighted,18,1.05 [0.99-1.12],0.113064995074971,trans
Chapter IX Diseases of the circulatory system,I9_AF,NCR1,Natural cytotoxicity triggering receptor 1,Inverse variance weighted,29,1.09 [0.98-1.21],0.113177775517499,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.18 [0.96-1.45],0.114231214521726,trans
Chapter IX Diseases of the circulatory system,I9_AF,ANGPTL7,Angiopoietin-related protein 7,Inverse variance weighted,7,0.77 [0.56-1.07],0.11480718174735,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G10,Group 10 secretory phospholipase A2,Inverse variance weighted,19,1.05 [0.99-1.12],0.116455856988362,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,0.96 [0.91-1.01],0.116576713843441,trans
Chapter IX Diseases of the circulatory system,I9_AF,LMNB2,Lamin-B2,Inverse variance weighted,8,1.31 [0.94-1.82],0.117058983128689,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL5A1,Collagen alpha-1(V) chain,Inverse variance weighted,16,0.93 [0.84-1.02],0.118353639153481,trans
Chapter IX Diseases of the circulatory system,I9_AF,DKK4,Dickkopf-related protein 4,Inverse variance weighted,15,0.85 [0.7-1.04],0.119429227204924,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD209,CD209 antigen,Inverse variance weighted,34,0.97 [0.94-1.01],0.12297878483556,trans
Chapter IX Diseases of the circulatory system,I9_AF,CILP,Cartilage intermediate layer protein 1,Inverse variance weighted,6,0.85 [0.7-1.04],0.12309510233358,trans
Chapter IX Diseases of the circulatory system,I9_AF,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.17 [0.96-1.42],0.123742762030263,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,1.05 [0.99-1.11],0.124397534591473,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.17 [0.96-1.42],0.125719649974139,trans
Chapter IX Diseases of the circulatory system,I9_AF,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.14 [0.96-1.34],0.126481409617987,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G7,Platelet-activating factor acetylhydrolase,Inverse variance weighted,18,1.13 [0.97-1.31],0.128070305856354,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC4M,C-type lectin domain family 4 member M,Inverse variance weighted,35,0.98 [0.95-1.01],0.128816377248868,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNR,Tenascin-R,Inverse variance weighted,19,0.9 [0.79-1.03],0.1288290171543,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL1RAP,Interleukin-1 receptor accessory protein,Inverse variance weighted,7,0.78 [0.56-1.08],0.13093248349642,trans
Chapter IX Diseases of the circulatory system,I9_AF,PI16,Peptidase inhibitor 16,Inverse variance weighted,22,1.05 [0.99-1.12],0.132007622416723,trans
Chapter IX Diseases of the circulatory system,I9_AF,F10,Coagulation factor X,Inverse variance weighted,11,0.93 [0.85-1.02],0.132105369928305,trans
Chapter IX Diseases of the circulatory system,I9_AF,BANK1,B-cell scaffold protein with ankyrin repeats,Inverse variance weighted,4,1.15 [0.96-1.37],0.132246392695543,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL20,C-C motif chemokine 20,Inverse variance weighted,6,0.86 [0.71-1.05],0.133980002318747,trans
Chapter IX Diseases of the circulatory system,I9_AF,APOL1,Apolipoprotein L1,Inverse variance weighted,46,0.97 [0.93-1.01],0.135579397164645,trans
Chapter IX Diseases of the circulatory system,I9_AF,KIT,Mast/stem cell growth factor receptor Kit,Inverse variance weighted,47,1.06 [0.98-1.14],0.136961266511258,trans
Chapter IX Diseases of the circulatory system,I9_AF,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.81 [0.61-1.07],0.137034223779064,trans
Chapter IX Diseases of the circulatory system,I9_AF,CALCB,Calcitonin gene-related peptide 2,Inverse variance weighted,3,0.73 [0.48-1.11],0.137104291333637,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1.14 [0.96-1.36],0.138920318369653,trans
Chapter IX Diseases of the circulatory system,I9_AF,ESM1,Endothelial cell-specific molecule 1,Inverse variance weighted,21,1.09 [0.97-1.23],0.141548930006981,trans
Chapter IX Diseases of the circulatory system,I9_AF,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,Inverse variance weighted,27,1.1 [0.97-1.25],0.148992211297631,trans
Chapter IX Diseases of the circulatory system,I9_AF,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,1.08 [0.97-1.21],0.151517638804112,trans
Chapter IX Diseases of the circulatory system,I9_AF,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,0.9 [0.78-1.04],0.151998299474016,trans
Chapter IX Diseases of the circulatory system,I9_AF,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,Inverse variance weighted,22,1.06 [0.98-1.14],0.153068875970995,trans
Chapter IX Diseases of the circulatory system,I9_AF,NTF3,Neurotrophin-3,Inverse variance weighted,11,1.08 [0.97-1.2],0.154675633544312,trans
Chapter IX Diseases of the circulatory system,I9_AF,SETMAR,Histone-lysine N-methyltransferase SETMAR,Inverse variance weighted,2,1.34 [0.89-2.02],0.155544838256997,trans
Chapter IX Diseases of the circulatory system,I9_AF,EGLN1,Egl nine homolog 1,Wald ratio,1,1.39 [0.88-2.19],0.158352244150079,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL15,Interleukin-15,Inverse variance weighted,35,0.95 [0.89-1.02],0.159680659383276,trans
Chapter IX Diseases of the circulatory system,I9_AF,PCSK9,Proprotein convertase subtilisin/kexin type 9,Inverse variance weighted,9,1.15 [0.95-1.4],0.16048717938614,trans
Chapter IX Diseases of the circulatory system,I9_AF,NRP2,Neuropilin-2,Inverse variance weighted,14,1.11 [0.96-1.27],0.161993967705488,trans
Chapter IX Diseases of the circulatory system,I9_AF,OSMR,Oncostatin-M-specific receptor subunit beta,Inverse variance weighted,12,1.15 [0.94-1.41],0.16266663536252,trans
Chapter IX Diseases of the circulatory system,I9_AF,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,Inverse variance weighted,19,1.05 [0.98-1.11],0.165661377059459,trans
Chapter IX Diseases of the circulatory system,I9_AF,REN,Renin,Inverse variance weighted,8,0.66 [0.36-1.19],0.16601111887282,trans
Chapter IX Diseases of the circulatory system,I9_AF,NOTCH3,Neurogenic locus notch homolog protein 3,Inverse variance weighted,17,1.09 [0.96-1.24],0.168500226295042,trans
Chapter IX Diseases of the circulatory system,I9_AF,B4GAT1,"Beta-1,4-glucuronyltransferase 1",Inverse variance weighted,18,0.95 [0.88-1.02],0.17067176007031,trans
Chapter IX Diseases of the circulatory system,I9_AF,AREG,Amphiregulin,Inverse variance weighted,5,1.15 [0.94-1.41],0.175898995096836,trans
Chapter IX Diseases of the circulatory system,I9_AF,NFASC,Neurofascin,Inverse variance weighted,6,0.76 [0.51-1.13],0.179640924564476,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL18R1,Interleukin-18 receptor 1,Inverse variance weighted,22,0.95 [0.88-1.02],0.183139673505223,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.09 [0.96-1.25],0.185603170408203,trans
Chapter IX Diseases of the circulatory system,I9_AF,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,Inverse variance weighted,4,0.92 [0.81-1.04],0.187944369100726,trans
Chapter IX Diseases of the circulatory system,I9_AF,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.08 [0.96-1.21],0.188876186753888,trans
Chapter IX Diseases of the circulatory system,I9_AF,GRN,Progranulin,Inverse variance weighted,46,1.03 [0.99-1.07],0.189256000754464,trans
Chapter IX Diseases of the circulatory system,I9_AF,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,Inverse variance weighted,3,1.15 [0.93-1.41],0.189910173528445,trans
Chapter IX Diseases of the circulatory system,I9_AF,EDAR,Tumor necrosis factor receptor superfamily member EDAR,Inverse variance weighted,32,1.07 [0.97-1.18],0.190533391318978,trans
Chapter IX Diseases of the circulatory system,I9_AF,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,Wald ratio,1,1.31 [0.87-1.97],0.191806142310334,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.24 [0.9-1.73],0.192390864689369,trans
Chapter IX Diseases of the circulatory system,I9_AF,SNCG,Gamma-synuclein,Inverse variance weighted,47,0.98 [0.95-1.01],0.193509972027015,trans
Chapter IX Diseases of the circulatory system,I9_AF,LGALS4,Galectin-4,Inverse variance weighted,15,0.96 [0.9-1.02],0.195820660762074,trans
Chapter IX Diseases of the circulatory system,I9_AF,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.71 [0.42-1.2],0.196496282403464,trans
Chapter IX Diseases of the circulatory system,I9_AF,RARRES1,Retinoic acid receptor responder protein 1,Inverse variance weighted,8,1.09 [0.96-1.25],0.196899792527324,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,Inverse variance weighted,13,0.91 [0.79-1.05],0.197989292824155,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLK4,Kallikrein-4,Inverse variance weighted,5,0.85 [0.67-1.09],0.200012630459045,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,Inverse variance weighted,8,1.15 [0.93-1.42],0.200703505975697,trans
Chapter IX Diseases of the circulatory system,I9_AF,THBS4,Thrombospondin-4,Inverse variance weighted,11,0.91 [0.78-1.05],0.201929092929932,trans
Chapter IX Diseases of the circulatory system,I9_AF,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.22 [0.9-1.66],0.202814716891552,trans
Chapter IX Diseases of the circulatory system,I9_AF,S100G,Protein S100-G,Inverse variance weighted,4,1.21 [0.9-1.62],0.203141472193737,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRSS8,Prostasin,Inverse variance weighted,14,0.93 [0.84-1.04],0.203562690330915,trans
Chapter IX Diseases of the circulatory system,I9_AF,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,Inverse variance weighted,8,0.88 [0.72-1.07],0.206431235357922,trans
Chapter IX Diseases of the circulatory system,I9_AF,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.05 [0.97-1.13],0.206450111624991,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLKB1,Plasma kallikrein,Inverse variance weighted,20,1.05 [0.97-1.13],0.20694884664837,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.86 [0.67-1.09],0.208916808751359,trans
Chapter IX Diseases of the circulatory system,I9_AF,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.96 [0.91-1.02],0.209087959933139,trans
Chapter IX Diseases of the circulatory system,I9_AF,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,1.06 [0.97-1.15],0.209580489100658,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G1B,Phospholipase A2,Inverse variance weighted,20,0.94 [0.86-1.03],0.209990472925285,trans
Chapter IX Diseases of the circulatory system,I9_AF,DSC2,Desmocollin-2,Inverse variance weighted,16,0.94 [0.85-1.04],0.210471661141334,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD72,B-cell differentiation antigen CD72,Inverse variance weighted,10,1.09 [0.95-1.25],0.211934938004644,trans
Chapter IX Diseases of the circulatory system,I9_AF,MFAP5,Microfibrillar-associated protein 5,Inverse variance weighted,2,1.17 [0.91-1.5],0.212697272830001,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACTN2,Alpha-actinin-2,Inverse variance weighted,4,1.29 [0.86-1.94],0.215780386506794,trans
Chapter IX Diseases of the circulatory system,I9_AF,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.91 [0.79-1.06],0.221390647952115,trans
Chapter IX Diseases of the circulatory system,I9_AF,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1.03 [0.98-1.07],0.22513634170513,trans
Chapter IX Diseases of the circulatory system,I9_AF,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1.13 [0.93-1.38],0.226008998895314,trans
Chapter IX Diseases of the circulatory system,I9_AF,VAMP5,Vesicle-associated membrane protein 5,Wald ratio,1,0.76 [0.49-1.19],0.22721260119676,trans
Chapter IX Diseases of the circulatory system,I9_AF,ITGA5,Integrin alpha-5,Inverse variance weighted,18,0.94 [0.86-1.04],0.228176822223275,trans
Chapter IX Diseases of the circulatory system,I9_AF,GPRC5C,G-protein coupled receptor family C group 5 member C,Inverse variance weighted,7,1.08 [0.95-1.21],0.231518468291304,trans
Chapter IX Diseases of the circulatory system,I9_AF,PSG1,Pregnancy-specific beta-1-glycoprotein 1,Inverse variance weighted,14,1.11 [0.94-1.3],0.231541006062349,trans
Chapter IX Diseases of the circulatory system,I9_AF,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.09 [0.95-1.24],0.233373964080639,trans
Chapter IX Diseases of the circulatory system,I9_AF,C4BPB,C4b-binding protein beta chain,Inverse variance weighted,21,1.08 [0.95-1.23],0.233605967929582,trans
Chapter IX Diseases of the circulatory system,I9_AF,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,1.12 [0.93-1.34],0.234281379868305,trans
Chapter IX Diseases of the circulatory system,I9_AF,GSN,Gelsolin,Inverse variance weighted,7,1.09 [0.94-1.27],0.234537646946775,trans
Chapter IX Diseases of the circulatory system,I9_AF,CFC1,Cryptic protein,Inverse variance weighted,11,0.9 [0.76-1.07],0.234925586267438,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGA,Fibrinogen alpha chain,Inverse variance weighted,6,1.17 [0.9-1.53],0.23574076741224,trans
Chapter IX Diseases of the circulatory system,I9_AF,S100P,Protein S100-P,Inverse variance weighted,4,0.89 [0.73-1.08],0.237642111531201,trans
Chapter IX Diseases of the circulatory system,I9_AF,VWF,von Willebrand factor,Inverse variance weighted,6,0.92 [0.81-1.05],0.238326371168027,trans
Chapter IX Diseases of the circulatory system,I9_AF,TIMP2,Metalloproteinase inhibitor 2,Inverse variance weighted,3,0.87 [0.7-1.09],0.239913389959429,trans
Chapter IX Diseases of the circulatory system,I9_AF,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,1.12 [0.92-1.37],0.239928675727014,trans
Chapter IX Diseases of the circulatory system,I9_AF,BMPER,BMP-binding endothelial regulator protein,Inverse variance weighted,4,1.17 [0.9-1.53],0.240262284264595,trans
Chapter IX Diseases of the circulatory system,I9_AF,OSM,Oncostatin-M,Inverse variance weighted,6,1.07 [0.95-1.21],0.243564925128728,trans
Chapter IX Diseases of the circulatory system,I9_AF,MEP1B,Meprin A subunit beta,Inverse variance weighted,72,1.01 [0.99-1.03],0.246046140716851,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.03 [0.98-1.09],0.249851841404239,trans
Chapter IX Diseases of the circulatory system,I9_AF,NECTIN4,Nectin-4,Inverse variance weighted,4,0.79 [0.53-1.18],0.249935968139557,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD302,CD302 antigen,Inverse variance weighted,11,0.93 [0.82-1.05],0.251354799049889,trans
Chapter IX Diseases of the circulatory system,I9_AF,ESAM,Endothelial cell-selective adhesion molecule,Inverse variance weighted,2,1.15 [0.91-1.46],0.253805711747581,trans
Chapter IX Diseases of the circulatory system,I9_AF,PILRB,Paired immunoglobulin-like type 2 receptor beta,Inverse variance weighted,30,0.98 [0.95-1.01],0.254450013532451,trans
Chapter IX Diseases of the circulatory system,I9_AF,ASAH2,Neutral ceramidase,Inverse variance weighted,43,0.98 [0.94-1.02],0.25471206782069,trans
Chapter IX Diseases of the circulatory system,I9_AF,BMP10,Bone morphogenetic protein 10,Inverse variance weighted,19,1.06 [0.96-1.17],0.25527582134391,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,Inverse variance weighted,17,1.07 [0.95-1.2],0.255859941370191,trans
Chapter IX Diseases of the circulatory system,I9_AF,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,1.17 [0.89-1.54],0.255997490654272,trans
Chapter IX Diseases of the circulatory system,I9_AF,CR2,Complement receptor type 2,Inverse variance weighted,36,1.06 [0.96-1.18],0.25628491309051,trans
Chapter IX Diseases of the circulatory system,I9_AF,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,0.91 [0.78-1.07],0.260073363781386,trans
Chapter IX Diseases of the circulatory system,I9_AF,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.15 [0.9-1.47],0.262926251279774,trans
Chapter IX Diseases of the circulatory system,I9_AF,VWA1,von Willebrand factor A domain-containing protein 1,Inverse variance weighted,5,0.9 [0.74-1.08],0.263019541482335,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD160,CD160 antigen,Inverse variance weighted,24,1.05 [0.96-1.14],0.265382877870637,trans
Chapter IX Diseases of the circulatory system,I9_AF,GAL,Galanin peptides,Inverse variance weighted,49,1.04 [0.97-1.13],0.266212396094914,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADGRB3,Adhesion G protein-coupled receptor B3,Inverse variance weighted,43,0.98 [0.95-1.01],0.270342782535208,trans
Chapter IX Diseases of the circulatory system,I9_AF,CST3,Cystatin-C,Inverse variance weighted,3,0.77 [0.48-1.23],0.270571138601389,trans
Chapter IX Diseases of the circulatory system,I9_AF,LCAT,Phosphatidylcholine-sterol acyltransferase,Inverse variance weighted,11,1.09 [0.93-1.27],0.271659209656514,trans
Chapter IX Diseases of the circulatory system,I9_AF,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.05 [0.96-1.16],0.271696119268745,trans
Chapter IX Diseases of the circulatory system,I9_AF,IFNGR1,Interferon gamma receptor 1,Inverse variance weighted,7,1.13 [0.91-1.39],0.272647320002432,trans
Chapter IX Diseases of the circulatory system,I9_AF,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",Inverse variance weighted,2,1.18 [0.88-1.58],0.276067088396957,trans
Chapter IX Diseases of the circulatory system,I9_AF,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,Inverse variance weighted,48,0.97 [0.91-1.03],0.277415019165497,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF12,Tumor necrosis factor ligand superfamily member 12,Inverse variance weighted,20,1.06 [0.96-1.17],0.277608257820202,trans
Chapter IX Diseases of the circulatory system,I9_AF,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,Inverse variance weighted,38,1.03 [0.97-1.09],0.280159188113207,trans
Chapter IX Diseases of the circulatory system,I9_AF,CDHR5,Cadherin-related family member 5,Inverse variance weighted,16,1.06 [0.95-1.19],0.284144717749564,trans
Chapter IX Diseases of the circulatory system,I9_AF,TINAGL1,Tubulointerstitial nephritis antigen-like,Inverse variance weighted,13,0.9 [0.75-1.09],0.288505316812273,trans
Chapter IX Diseases of the circulatory system,I9_AF,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",Inverse variance weighted,16,1.06 [0.95-1.18],0.289380415901588,trans
Chapter IX Diseases of the circulatory system,I9_AF,MYBPC1,"Myosin-binding protein C, slow-type",Inverse variance weighted,13,1.12 [0.91-1.37],0.291167979372492,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLRB1,Killer cell lectin-like receptor subfamily B member 1,Inverse variance weighted,17,0.94 [0.85-1.05],0.292977810250953,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.21 [0.85-1.74],0.296060559704831,trans
Chapter IX Diseases of the circulatory system,I9_AF,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,0.77 [0.46-1.26],0.296077314547048,trans
Chapter IX Diseases of the circulatory system,I9_AF,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.15 [0.88-1.52],0.299456360107867,trans
Chapter IX Diseases of the circulatory system,I9_AF,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.08 [0.93-1.24],0.300012352192069,trans
Chapter IX Diseases of the circulatory system,I9_AF,THPO,Thrombopoietin,Inverse variance weighted,12,0.94 [0.83-1.06],0.302323414412069,trans
Chapter IX Diseases of the circulatory system,I9_AF,PAM,Peptidyl-glycine alpha-amidating monooxygenase,Inverse variance weighted,24,0.97 [0.93-1.02],0.303116309069664,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,0.98 [0.95-1.02],0.304827855329321,trans
Chapter IX Diseases of the circulatory system,I9_AF,CGA,Glycoprotein hormones alpha chain,Inverse variance weighted,2,1.21 [0.84-1.75],0.306253448891053,trans
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC9,Sialic acid-binding Ig-like lectin 9,Inverse variance weighted,67,0.98 [0.96-1.01],0.306347128113923,trans
Chapter IX Diseases of the circulatory system,I9_AF,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,1.15 [0.88-1.52],0.308238242966797,trans
Chapter IX Diseases of the circulatory system,I9_AF,PROS1,Vitamin K-dependent protein S,Inverse variance weighted,14,1.05 [0.96-1.14],0.309131714761953,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRTG,Protogenin,Inverse variance weighted,8,1.13 [0.89-1.45],0.310699666287722,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,0.94 [0.82-1.06],0.311048283190238,trans
Chapter IX Diseases of the circulatory system,I9_AF,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,Inverse variance weighted,14,0.97 [0.92-1.03],0.311287232639172,trans
Chapter IX Diseases of the circulatory system,I9_AF,MCAM,Cell surface glycoprotein MUC18,Inverse variance weighted,11,1.06 [0.95-1.17],0.313889831285185,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD248,Endosialin,Inverse variance weighted,17,1.09 [0.93-1.27],0.313958402281754,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.2 [0.84-1.71],0.314909176325228,trans
Chapter IX Diseases of the circulatory system,I9_AF,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,0.95 [0.85-1.05],0.315426540203655,trans
Chapter IX Diseases of the circulatory system,I9_AF,MEGF9,Multiple epidermal growth factor-like domains protein 9,Inverse variance weighted,22,1.04 [0.97-1.11],0.315687228992554,trans
Chapter IX Diseases of the circulatory system,I9_AF,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,Inverse variance weighted,12,1.09 [0.92-1.3],0.316726982206115,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.94 [0.83-1.06],0.317252663089479,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,1.14 [0.88-1.46],0.319658647891365,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL19,Interleukin-19,Inverse variance weighted,10,0.96 [0.89-1.04],0.320457840382382,trans
Chapter IX Diseases of the circulatory system,I9_AF,B2M,Beta-2-microglobulin,Inverse variance weighted,7,0.84 [0.59-1.19],0.320805899382437,trans
Chapter IX Diseases of the circulatory system,I9_AF,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.13 [0.89-1.43],0.325087975878535,trans
Chapter IX Diseases of the circulatory system,I9_AF,BGLAP,Osteocalcin,Inverse variance weighted,8,1.09 [0.92-1.29],0.325148001315463,trans
Chapter IX Diseases of the circulatory system,I9_AF,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.03 [0.97-1.1],0.326608836577809,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRL,Prolactin,Inverse variance weighted,7,1.12 [0.9-1.39],0.327710061701828,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTSL4,ADAMTS-like protein 4,Inverse variance weighted,6,0.93 [0.8-1.08],0.32784663439822,trans
Chapter IX Diseases of the circulatory system,I9_AF,SORBS1,Sorbin and SH3 domain-containing protein 1,Inverse variance weighted,2,0.87 [0.65-1.16],0.329459122777918,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL17C,Interleukin-17C,Inverse variance weighted,5,0.87 [0.66-1.15],0.331203320775984,trans
Chapter IX Diseases of the circulatory system,I9_AF,MANSC1,MANSC domain-containing protein 1,Inverse variance weighted,15,0.93 [0.8-1.08],0.332441239103866,trans
Chapter IX Diseases of the circulatory system,I9_AF,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,1.25 [0.79-1.97],0.333278543854763,trans
Chapter IX Diseases of the circulatory system,I9_AF,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,0.89 [0.7-1.13],0.334602087804422,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTSL2,ADAMTS-like protein 2,Inverse variance weighted,9,0.94 [0.84-1.06],0.335368657455241,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPP1,Osteopontin,Inverse variance weighted,13,1.12 [0.89-1.4],0.335978128219896,trans
Chapter IX Diseases of the circulatory system,I9_AF,HEPH,Hephaestin,Inverse variance weighted,6,0.94 [0.82-1.07],0.336714016601722,trans
Chapter IX Diseases of the circulatory system,I9_AF,SOD3,Extracellular superoxide dismutase,Inverse variance weighted,7,1.07 [0.93-1.23],0.337151465946546,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,1.15 [0.87-1.52],0.337433585316808,trans
Chapter IX Diseases of the circulatory system,I9_AF,LY9,T-lymphocyte surface antigen Ly-9,Inverse variance weighted,11,0.93 [0.79-1.08],0.337796340515263,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,1.12 [0.89-1.42],0.337942933495594,trans
Chapter IX Diseases of the circulatory system,I9_AF,GPC5,Glypican-5,Inverse variance weighted,42,1.02 [0.98-1.06],0.338080680764173,trans
Chapter IX Diseases of the circulatory system,I9_AF,PDCD1LG2,Programmed cell death 1 ligand 2,Inverse variance weighted,36,0.98 [0.94-1.02],0.341469292807945,trans
Chapter IX Diseases of the circulatory system,I9_AF,GIPC2,PDZ domain-containing protein GIPC2,Inverse variance weighted,2,1.2 [0.82-1.75],0.344338478300029,trans
Chapter IX Diseases of the circulatory system,I9_AF,CRLF1,Cytokine receptor-like factor 1,Inverse variance weighted,15,0.91 [0.76-1.1],0.344751084312617,trans
Chapter IX Diseases of the circulatory system,I9_AF,TCOF1,Treacle protein,Wald ratio,1,1.25 [0.79-1.96],0.344965883048536,trans
Chapter IX Diseases of the circulatory system,I9_AF,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.08 [0.92-1.26],0.344985111796928,trans
Chapter IX Diseases of the circulatory system,I9_AF,GGT5,Glutathione hydrolase 5 proenzyme,Inverse variance weighted,2,0.68 [0.31-1.51],0.347831996830835,trans
Chapter IX Diseases of the circulatory system,I9_AF,INSL5,Insulin-like peptide INSL5,Inverse variance weighted,8,1.11 [0.89-1.38],0.347893703593016,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,0.98 [0.94-1.02],0.348156377297033,trans
Chapter IX Diseases of the circulatory system,I9_AF,MENT,Protein MENT,Inverse variance weighted,28,0.97 [0.92-1.03],0.348287668536779,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPOCK1,Testican-1,Inverse variance weighted,26,0.95 [0.84-1.06],0.348972380118722,trans
Chapter IX Diseases of the circulatory system,I9_AF,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,1.09 [0.91-1.3],0.349298001735531,trans
Chapter IX Diseases of the circulatory system,I9_AF,INSL4,Early placenta insulin-like peptide,Inverse variance weighted,4,0.93 [0.81-1.08],0.350966797741799,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.91 [0.74-1.11],0.352298521956453,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL12A_IL12B,Interleukin-12,Inverse variance weighted,56,0.98 [0.94-1.02],0.355307003247658,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.11 [0.89-1.38],0.355688017396521,trans
Chapter IX Diseases of the circulatory system,I9_AF,SUSD2,Sushi domain-containing protein 2,Inverse variance weighted,16,1.07 [0.92-1.25],0.356196936057345,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.12 [0.88-1.41],0.360294810850104,trans
Chapter IX Diseases of the circulatory system,I9_AF,SEMA4C,Semaphorin-4C,Inverse variance weighted,3,0.9 [0.72-1.13],0.361820904611715,trans
Chapter IX Diseases of the circulatory system,I9_AF,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,1.06 [0.93-1.22],0.364621706183355,trans
Chapter IX Diseases of the circulatory system,I9_AF,FBLN2,Fibulin-2,Inverse variance weighted,6,1.13 [0.86-1.49],0.372497065266363,trans
Chapter IX Diseases of the circulatory system,I9_AF,APOA1,Apolipoprotein A-I,Inverse variance weighted,13,1.06 [0.94-1.19],0.374404059053292,trans
Chapter IX Diseases of the circulatory system,I9_AF,APOC1,Apolipoprotein C-I,Inverse variance weighted,12,0.96 [0.87-1.05],0.376052062615698,trans
Chapter IX Diseases of the circulatory system,I9_AF,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,0.95 [0.85-1.07],0.378476017791147,trans
Chapter IX Diseases of the circulatory system,I9_AF,THBS2,Thrombospondin-2,Inverse variance weighted,15,0.97 [0.9-1.04],0.379504404015206,trans
Chapter IX Diseases of the circulatory system,I9_AF,IDS,Iduronate 2-sulfatase,Inverse variance weighted,3,1.06 [0.94-1.19],0.379601280179942,trans
Chapter IX Diseases of the circulatory system,I9_AF,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,0.91 [0.73-1.13],0.381922775093958,trans
Chapter IX Diseases of the circulatory system,I9_AF,GUCA2A,Guanylin,Inverse variance weighted,7,1.07 [0.92-1.24],0.382414391591174,trans
Chapter IX Diseases of the circulatory system,I9_AF,SLITRK1,SLIT and NTRK-like protein 1,Inverse variance weighted,6,0.9 [0.7-1.15],0.386986144805444,trans
Chapter IX Diseases of the circulatory system,I9_AF,TACC3,Transforming acidic coiled-coil-containing protein 3,Wald ratio,1,0.88 [0.66-1.17],0.387223367689236,trans
Chapter IX Diseases of the circulatory system,I9_AF,SEZ6L2,Seizure 6-like protein 2,Inverse variance weighted,9,0.94 [0.82-1.08],0.387348184148481,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.94 [0.82-1.08],0.387682500054398,trans
Chapter IX Diseases of the circulatory system,I9_AF,LGALS3,Galectin-3,Inverse variance weighted,15,0.94 [0.81-1.09],0.392115191569623,trans
Chapter IX Diseases of the circulatory system,I9_AF,MPO,Myeloperoxidase,Inverse variance weighted,17,1.03 [0.96-1.12],0.394328770696445,trans
Chapter IX Diseases of the circulatory system,I9_AF,POSTN,Periostin,Inverse variance weighted,14,1.03 [0.97-1.09],0.395010186345619,trans
Chapter IX Diseases of the circulatory system,I9_AF,KDR,Vascular endothelial growth factor receptor 2,Inverse variance weighted,25,0.95 [0.85-1.07],0.395913719165562,trans
Chapter IX Diseases of the circulatory system,I9_AF,PENK,Proenkephalin-A,Inverse variance weighted,15,1.04 [0.95-1.14],0.399631504003644,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCN4,CCN family member 4,Inverse variance weighted,29,1.02 [0.97-1.08],0.402331557412978,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL18,C-C motif chemokine 18,Inverse variance weighted,19,1.02 [0.98-1.06],0.402483115318421,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC11A,C-type lectin domain family 11 member A,Inverse variance weighted,14,1.08 [0.9-1.28],0.403373946446191,trans
Chapter IX Diseases of the circulatory system,I9_AF,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,0.8 [0.48-1.34],0.403501890232987,trans
Chapter IX Diseases of the circulatory system,I9_AF,MIA,Melanoma-derived growth regulatory protein,Inverse variance weighted,14,0.94 [0.81-1.09],0.404438130431944,trans
Chapter IX Diseases of the circulatory system,I9_AF,ALCAM,CD166 antigen,Inverse variance weighted,4,1.06 [0.92-1.22],0.405332044283931,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,0.78 [0.43-1.41],0.409060779008716,trans
Chapter IX Diseases of the circulatory system,I9_AF,GGT1,Glutathione hydrolase 1 proenzyme,Inverse variance weighted,6,1.1 [0.88-1.38],0.411921635206592,trans
Chapter IX Diseases of the circulatory system,I9_AF,NRCAM,Neuronal cell adhesion molecule,Inverse variance weighted,7,1.08 [0.89-1.32],0.413232377245504,trans
Chapter IX Diseases of the circulatory system,I9_AF,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,Inverse variance weighted,6,0.92 [0.76-1.12],0.413413695555842,trans
Chapter IX Diseases of the circulatory system,I9_AF,GDF2,Growth/differentiation factor 2,Inverse variance weighted,31,1.03 [0.96-1.11],0.413861703788555,trans
Chapter IX Diseases of the circulatory system,I9_AF,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,1.09 [0.88-1.35],0.416891262404414,trans
Chapter IX Diseases of the circulatory system,I9_AF,LAMA4,Laminin subunit alpha-4,Inverse variance weighted,15,1.05 [0.94-1.17],0.417756959812434,trans
Chapter IX Diseases of the circulatory system,I9_AF,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,0.94 [0.82-1.09],0.419024261367319,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.06 [0.92-1.23],0.422989900384721,trans
Chapter IX Diseases of the circulatory system,I9_AF,ITGBL1,Integrin beta-like protein 1,Inverse variance weighted,5,1.15 [0.82-1.6],0.42307119615906,trans
Chapter IX Diseases of the circulatory system,I9_AF,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.91 [0.72-1.15],0.426417394594873,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,0.98 [0.94-1.03],0.426863875680493,trans
Chapter IX Diseases of the circulatory system,I9_AF,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,0.85 [0.57-1.26],0.426880291636553,trans
Chapter IX Diseases of the circulatory system,I9_AF,TFPI2,Tissue factor pathway inhibitor 2,Inverse variance weighted,15,0.94 [0.81-1.09],0.427958956912139,trans
Chapter IX Diseases of the circulatory system,I9_AF,ANGPTL1,Angiopoietin-related protein 1,Inverse variance weighted,7,1.09 [0.88-1.34],0.428223149842291,trans
Chapter IX Diseases of the circulatory system,I9_AF,LGALS9,Galectin-9,Inverse variance weighted,36,1.02 [0.97-1.06],0.430663218326653,trans
Chapter IX Diseases of the circulatory system,I9_AF,NPTX2,Neuronal pentraxin-2,Inverse variance weighted,7,1.13 [0.84-1.52],0.431138840638852,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACP5,Tartrate-resistant acid phosphatase type 5,Inverse variance weighted,16,0.96 [0.86-1.07],0.431529122034016,trans
Chapter IX Diseases of the circulatory system,I9_AF,F9,Coagulation factor IX,Inverse variance weighted,3,1.1 [0.87-1.4],0.431718656366813,trans
Chapter IX Diseases of the circulatory system,I9_AF,ICAM5,Intercellular adhesion molecule 5,Inverse variance weighted,13,1.08 [0.89-1.31],0.431746054625389,trans
Chapter IX Diseases of the circulatory system,I9_AF,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,1.06 [0.92-1.21],0.434018611246929,trans
Chapter IX Diseases of the circulatory system,I9_AF,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,Inverse variance weighted,48,0.98 [0.93-1.03],0.435040593322816,trans
Chapter IX Diseases of the circulatory system,I9_AF,LGALS7_LGALS7B,Galectin-7,Inverse variance weighted,15,1.05 [0.93-1.19],0.435622954870961,trans
Chapter IX Diseases of the circulatory system,I9_AF,KRT18,"Keratin, type I cytoskeletal 18",Inverse variance weighted,7,1.05 [0.93-1.18],0.438428529858522,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLAU,Urokinase-type plasminogen activator,Inverse variance weighted,24,0.97 [0.91-1.04],0.439715037110361,trans
Chapter IX Diseases of the circulatory system,I9_AF,DEFA1_DEFA1B,Neutrophil defensin 1,Inverse variance weighted,31,1.03 [0.96-1.1],0.440567926803263,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL17D,Interleukin-17D,Inverse variance weighted,2,0.85 [0.56-1.29],0.444265310098257,trans
Chapter IX Diseases of the circulatory system,I9_AF,PCDH17,Protocadherin-17,Inverse variance weighted,44,0.98 [0.95-1.02],0.444733898435709,trans
Chapter IX Diseases of the circulatory system,I9_AF,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",Wald ratio,1,0.83 [0.52-1.33],0.44612084173657,trans
Chapter IX Diseases of the circulatory system,I9_AF,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,Inverse variance weighted,4,1.29 [0.67-2.46],0.448487747878604,trans
Chapter IX Diseases of the circulatory system,I9_AF,FLT1,Vascular endothelial growth factor receptor 1,Inverse variance weighted,16,1.03 [0.96-1.1],0.449496199475021,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.07 [0.9-1.27],0.45136128424912,trans
Chapter IX Diseases of the circulatory system,I9_AF,SEMA3G,Semaphorin-3G,Inverse variance weighted,66,1.02 [0.97-1.06],0.451425260608469,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.02 [0.97-1.07],0.451880744049701,trans
Chapter IX Diseases of the circulatory system,I9_AF,AXL,Tyrosine-protein kinase receptor UFO,Inverse variance weighted,15,1.06 [0.91-1.23],0.452429410798748,trans
Chapter IX Diseases of the circulatory system,I9_AF,HGF,Hepatocyte growth factor,Inverse variance weighted,5,0.9 [0.69-1.18],0.453759769563726,trans
Chapter IX Diseases of the circulatory system,I9_AF,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,1.05 [0.92-1.21],0.455594007276068,trans
Chapter IX Diseases of the circulatory system,I9_AF,GHR,Growth hormone receptor,Inverse variance weighted,26,1.04 [0.94-1.15],0.457940421161983,trans
Chapter IX Diseases of the circulatory system,I9_AF,PI3,Elafin,Inverse variance weighted,18,1.03 [0.96-1.1],0.458951055253714,trans
Chapter IX Diseases of the circulatory system,I9_AF,MILR1,Allergin-1,Inverse variance weighted,43,1.01 [0.99-1.03],0.46465311383484,trans
Chapter IX Diseases of the circulatory system,I9_AF,CPM,Carboxypeptidase M,Inverse variance weighted,19,1.05 [0.92-1.21],0.464694380675192,trans
Chapter IX Diseases of the circulatory system,I9_AF,PON1,Serum paraoxonase/arylesterase 1,Inverse variance weighted,28,1.03 [0.95-1.11],0.466047764977786,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGLC2,Immunoglobulin lambda constant 2,Inverse variance weighted,10,0.95 [0.81-1.1],0.468800779484049,trans
Chapter IX Diseases of the circulatory system,I9_AF,GAS6,Growth arrest-specific protein 6,Inverse variance weighted,18,1.04 [0.93-1.17],0.468934253551789,trans
Chapter IX Diseases of the circulatory system,I9_AF,NUCB2,Nucleobindin-2,Inverse variance weighted,2,0.84 [0.53-1.34],0.471594204913152,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,Inverse variance weighted,11,1.08 [0.88-1.32],0.471823822344175,trans
Chapter IX Diseases of the circulatory system,I9_AF,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.95 [0.84-1.09],0.472214717943213,trans
Chapter IX Diseases of the circulatory system,I9_AF,ANXA11,Annexin A11,Inverse variance weighted,3,0.92 [0.73-1.16],0.472245124301199,trans
Chapter IX Diseases of the circulatory system,I9_AF,CNTN4,Contactin-4,Inverse variance weighted,12,1.06 [0.9-1.25],0.473343659606521,trans
Chapter IX Diseases of the circulatory system,I9_AF,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.92 [0.73-1.16],0.475528821383944,trans
Chapter IX Diseases of the circulatory system,I9_AF,PDGFRA,Platelet-derived growth factor receptor alpha,Inverse variance weighted,16,1.05 [0.92-1.2],0.479168778111608,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL1RL2,Interleukin-1 receptor-like 2,Inverse variance weighted,27,1.03 [0.94-1.13],0.479254875567852,trans
Chapter IX Diseases of the circulatory system,I9_AF,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,0.95 [0.82-1.1],0.479264947044576,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,0.97 [0.88-1.06],0.481147996346424,trans
Chapter IX Diseases of the circulatory system,I9_AF,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,0.89 [0.63-1.24],0.48227302988976,trans
Chapter IX Diseases of the circulatory system,I9_AF,APOA2,Apolipoprotein A-II,Inverse variance weighted,15,0.95 [0.83-1.09],0.482787398534004,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP3,Insulin-like growth factor-binding protein 3,Inverse variance weighted,11,0.93 [0.75-1.15],0.484858973123846,trans
Chapter IX Diseases of the circulatory system,I9_AF,REG1B,Lithostathine-1-beta,Inverse variance weighted,7,0.95 [0.83-1.1],0.487232315328508,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD48,CD48 antigen,Inverse variance weighted,14,1.05 [0.91-1.22],0.487653108559841,trans
Chapter IX Diseases of the circulatory system,I9_AF,PON3,Serum paraoxonase/lactonase 3,Inverse variance weighted,12,1.03 [0.94-1.14],0.487654372502964,trans
Chapter IX Diseases of the circulatory system,I9_AF,CSF1R,Macrophage colony-stimulating factor 1 receptor,Inverse variance weighted,21,0.97 [0.89-1.06],0.490504736825097,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCGB1A1,Uteroglobin,Inverse variance weighted,38,1.02 [0.96-1.1],0.491505219751799,trans
Chapter IX Diseases of the circulatory system,I9_AF,CALCA,Calcitonin,Inverse variance weighted,13,1.09 [0.86-1.37],0.491823780206929,trans
Chapter IX Diseases of the circulatory system,I9_AF,PTX3,Pentraxin-related protein PTX3,Inverse variance weighted,13,0.98 [0.93-1.04],0.492462658680343,trans
Chapter IX Diseases of the circulatory system,I9_AF,PGLYRP1,Peptidoglycan recognition protein 1,Inverse variance weighted,16,1.05 [0.92-1.19],0.493234989844866,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD99,CD99 antigen,Inverse variance weighted,4,1.06 [0.89-1.26],0.496881385854741,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,Inverse variance weighted,2,1.25 [0.65-2.39],0.49894939562354,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.07 [0.88-1.31],0.501125542349157,trans
Chapter IX Diseases of the circulatory system,I9_AF,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,1.1 [0.83-1.48],0.502038305383222,trans
Chapter IX Diseases of the circulatory system,I9_AF,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.06 [0.9-1.24],0.503848189574772,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD1C,T-cell surface glycoprotein CD1c,Inverse variance weighted,28,1.03 [0.94-1.13],0.504600803788908,trans
Chapter IX Diseases of the circulatory system,I9_AF,DSG2,Desmoglein-2,Inverse variance weighted,22,1.02 [0.96-1.08],0.504698979794193,trans
Chapter IX Diseases of the circulatory system,I9_AF,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.98 [0.93-1.04],0.507993778257664,trans
Chapter IX Diseases of the circulatory system,I9_AF,CRTAM,Cytotoxic and regulatory T-cell molecule,Inverse variance weighted,13,0.95 [0.83-1.1],0.508180178643434,trans
Chapter IX Diseases of the circulatory system,I9_AF,QPCT,Glutaminyl-peptide cyclotransferase,Inverse variance weighted,9,1.07 [0.87-1.32],0.508257910023695,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,0.92 [0.71-1.19],0.508486327039726,trans
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1.04 [0.93-1.16],0.510147082201549,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGF2R,Cation-independent mannose-6-phosphate receptor,Inverse variance weighted,19,1.06 [0.89-1.26],0.514115466100859,trans
Chapter IX Diseases of the circulatory system,I9_AF,CTSV,Cathepsin L2,Inverse variance weighted,34,1.03 [0.95-1.1],0.515545339788665,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.04 [0.92-1.17],0.516758845897051,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD93,Complement component C1q receptor,Inverse variance weighted,2,1.09 [0.85-1.39],0.516839351539424,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCRG1,Scrapie-responsive protein 1,Inverse variance weighted,2,0.73 [0.28-1.89],0.517745337454361,trans
Chapter IX Diseases of the circulatory system,I9_AF,NRP1,Neuropilin-1,Inverse variance weighted,14,1.05 [0.91-1.21],0.518360916350429,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,0.93 [0.74-1.16],0.519194121756187,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,0.95 [0.82-1.1],0.524182433685142,trans
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC10,Sialic acid-binding Ig-like lectin 10,Inverse variance weighted,8,1.06 [0.88-1.28],0.525347292668632,trans
Chapter IX Diseases of the circulatory system,I9_AF,EFCAB14,EF-hand calcium-binding domain-containing protein 14,Inverse variance weighted,3,1.34 [0.54-3.33],0.527567618058263,trans
Chapter IX Diseases of the circulatory system,I9_AF,RARRES2,Retinoic acid receptor responder protein 2,Inverse variance weighted,2,1.1 [0.82-1.47],0.531960824778094,trans
Chapter IX Diseases of the circulatory system,I9_AF,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,Wald ratio,1,0.87 [0.57-1.34],0.532725205057821,trans
Chapter IX Diseases of the circulatory system,I9_AF,RBP7,Retinoid-binding protein 7,Inverse variance weighted,5,0.93 [0.75-1.16],0.533761254375903,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.03 [0.93-1.15],0.534799155827711,trans
Chapter IX Diseases of the circulatory system,I9_AF,SEMA3F,Semaphorin-3F,Inverse variance weighted,32,1.03 [0.94-1.12],0.53591261118384,trans
Chapter IX Diseases of the circulatory system,I9_AF,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,Inverse variance weighted,9,0.94 [0.77-1.15],0.538254789748712,trans
Chapter IX Diseases of the circulatory system,I9_AF,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,Inverse variance weighted,5,1.09 [0.83-1.41],0.540360915269533,trans
Chapter IX Diseases of the circulatory system,I9_AF,GOLM2,Protein GOLM2,Inverse variance weighted,14,1.02 [0.95-1.11],0.540854397612982,trans
Chapter IX Diseases of the circulatory system,I9_AF,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,Inverse variance weighted,2,0.94 [0.76-1.15],0.542799757291049,trans
Chapter IX Diseases of the circulatory system,I9_AF,RSPO1,R-spondin-1,Inverse variance weighted,8,1.05 [0.91-1.21],0.544109319807232,trans
Chapter IX Diseases of the circulatory system,I9_AF,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,Inverse variance weighted,25,1.04 [0.92-1.17],0.544438033039941,trans
Chapter IX Diseases of the circulatory system,I9_AF,TGFBR1,TGF-beta receptor type-1,Wald ratio,1,0.89 [0.61-1.3],0.546924687813167,trans
Chapter IX Diseases of the circulatory system,I9_AF,DDC,Aromatic-L-amino-acid decarboxylase,Inverse variance weighted,6,0.93 [0.72-1.19],0.549841563488099,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL9A1,Collagen alpha-1(IX) chain,Inverse variance weighted,7,1.06 [0.87-1.3],0.550002782793513,trans
Chapter IX Diseases of the circulatory system,I9_AF,RTBDN,Retbindin,Inverse variance weighted,2,1.23 [0.62-2.43],0.55191746264386,trans
Chapter IX Diseases of the circulatory system,I9_AF,NPTXR,Neuronal pentraxin receptor,Inverse variance weighted,10,0.95 [0.81-1.12],0.55353064100746,trans
Chapter IX Diseases of the circulatory system,I9_AF,LY96,Lymphocyte antigen 96,Inverse variance weighted,16,1.05 [0.89-1.25],0.553556395328109,trans
Chapter IX Diseases of the circulatory system,I9_AF,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,1.37 [0.48-3.91],0.554199790281234,trans
Chapter IX Diseases of the circulatory system,I9_AF,PTH,Parathyroid hormone,Inverse variance weighted,11,1.06 [0.87-1.31],0.556611262002417,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCGB3A2,Secretoglobin family 3A member 2,Inverse variance weighted,27,1.02 [0.96-1.09],0.558627169214092,trans
Chapter IX Diseases of the circulatory system,I9_AF,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.98 [0.9-1.06],0.559302219954266,trans
Chapter IX Diseases of the circulatory system,I9_AF,XG,Glycoprotein Xg,Inverse variance weighted,2,1.17 [0.68-2.01],0.561954977243962,trans
Chapter IX Diseases of the circulatory system,I9_AF,SFRP1,Secreted frizzled-related protein 1,Inverse variance weighted,9,1.05 [0.9-1.22],0.563454747807023,trans
Chapter IX Diseases of the circulatory system,I9_AF,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,1.08 [0.83-1.4],0.563951194828151,trans
Chapter IX Diseases of the circulatory system,I9_AF,CTSS,Cathepsin S,Inverse variance weighted,7,1.06 [0.87-1.3],0.564980770553637,trans
Chapter IX Diseases of the circulatory system,I9_AF,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",Inverse variance weighted,4,1.04 [0.91-1.2],0.566982031606526,trans
Chapter IX Diseases of the circulatory system,I9_AF,CSRP3,Cysteine and glycine-rich protein 3,Inverse variance weighted,3,0.88 [0.58-1.35],0.567457771174138,trans
Chapter IX Diseases of the circulatory system,I9_AF,CNTN3,Contactin-3,Inverse variance weighted,20,0.96 [0.84-1.1],0.567505323064738,trans
Chapter IX Diseases of the circulatory system,I9_AF,NECTIN2,Nectin-2,Inverse variance weighted,3,0.73 [0.25-2.14],0.570758536346037,trans
Chapter IX Diseases of the circulatory system,I9_AF,FAM3B,Protein FAM3B,Inverse variance weighted,26,1.01 [0.97-1.05],0.571095915823938,trans
Chapter IX Diseases of the circulatory system,I9_AF,DPP4,Dipeptidyl peptidase 4,Inverse variance weighted,8,0.96 [0.85-1.1],0.571291496889131,trans
Chapter IX Diseases of the circulatory system,I9_AF,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.01 [0.97-1.05],0.575376792547855,trans
Chapter IX Diseases of the circulatory system,I9_AF,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,Inverse variance weighted,7,1.06 [0.87-1.28],0.576643619819739,trans
Chapter IX Diseases of the circulatory system,I9_AF,SLAMF1,Signaling lymphocytic activation molecule,Inverse variance weighted,4,0.93 [0.72-1.2],0.578865645118286,trans
Chapter IX Diseases of the circulatory system,I9_AF,SLAMF7,SLAM family member 7,Inverse variance weighted,16,1.04 [0.91-1.19],0.582164165315245,trans
Chapter IX Diseases of the circulatory system,I9_AF,LECT2,Leukocyte cell-derived chemotaxin-2,Inverse variance weighted,11,1.06 [0.87-1.29],0.582376082237233,trans
Chapter IX Diseases of the circulatory system,I9_AF,C1QA,Complement C1q subcomponent subunit A,Inverse variance weighted,19,0.97 [0.88-1.08],0.586797291685839,trans
Chapter IX Diseases of the circulatory system,I9_AF,TGFB1,Transforming growth factor beta-1 proprotein,Inverse variance weighted,4,0.95 [0.78-1.15],0.586934949708345,trans
Chapter IX Diseases of the circulatory system,I9_AF,CDH1,Cadherin-1,Inverse variance weighted,16,0.98 [0.9-1.06],0.588329709382714,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPON2,Spondin-2,Inverse variance weighted,3,1.07 [0.83-1.4],0.589572738164887,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLAT,Tissue-type plasminogen activator,Inverse variance weighted,5,0.96 [0.81-1.13],0.589875531854462,trans
Chapter IX Diseases of the circulatory system,I9_AF,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.07 [0.83-1.38],0.590459322706112,trans
Chapter IX Diseases of the circulatory system,I9_AF,SDC4,Syndecan-4,Inverse variance weighted,35,1.02 [0.95-1.1],0.592362225833521,trans
Chapter IX Diseases of the circulatory system,I9_AF,VSNL1,Visinin-like protein 1,Inverse variance weighted,9,1.03 [0.93-1.14],0.593176211086662,trans
Chapter IX Diseases of the circulatory system,I9_AF,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,0.93 [0.72-1.21],0.59492809489548,trans
Chapter IX Diseases of the circulatory system,I9_AF,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,1.02 [0.94-1.11],0.600837751937884,trans
Chapter IX Diseases of the circulatory system,I9_AF,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.96 [0.84-1.11],0.60150281620978,trans
Chapter IX Diseases of the circulatory system,I9_AF,RETN,Resistin,Inverse variance weighted,19,0.97 [0.85-1.1],0.601849513208227,trans
Chapter IX Diseases of the circulatory system,I9_AF,CX3CL1,Fractalkine,Inverse variance weighted,12,0.95 [0.78-1.16],0.603039389878789,trans
Chapter IX Diseases of the circulatory system,I9_AF,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,1.03 [0.91-1.17],0.603675148061346,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.94 [0.73-1.2],0.604633517451426,trans
Chapter IX Diseases of the circulatory system,I9_AF,CREG1,Protein CREG1,Inverse variance weighted,20,0.98 [0.93-1.04],0.607224050331355,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.98 [0.93-1.04],0.609903253725159,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCN5,CCN family member 5,Inverse variance weighted,12,1.02 [0.95-1.09],0.612088469231727,trans
Chapter IX Diseases of the circulatory system,I9_AF,VEGFD,Vascular endothelial growth factor D,Inverse variance weighted,7,0.98 [0.89-1.07],0.612679431966018,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,0.96 [0.82-1.13],0.612723439901507,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD300LF,CMRF35-like molecule 1,Inverse variance weighted,34,0.99 [0.97-1.02],0.61510323559941,trans
Chapter IX Diseases of the circulatory system,I9_AF,STC2,Stanniocalcin-2,Inverse variance weighted,10,0.96 [0.81-1.14],0.617324608334554,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.83 [0.41-1.71],0.618312991332662,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLSTN3,Calsyntenin-3,Inverse variance weighted,7,0.96 [0.84-1.11],0.619043150167565,trans
Chapter IX Diseases of the circulatory system,I9_AF,MYL3,Myosin light chain 3,Inverse variance weighted,14,1.05 [0.86-1.28],0.619700634947701,trans
Chapter IX Diseases of the circulatory system,I9_AF,XCL1,Lymphotactin,Inverse variance weighted,15,1.05 [0.86-1.29],0.621561858248483,trans
Chapter IX Diseases of the circulatory system,I9_AF,CDH2,Cadherin-2,Inverse variance weighted,21,1.03 [0.93-1.13],0.622387159752918,trans
Chapter IX Diseases of the circulatory system,I9_AF,CNTN1,Contactin-1,Inverse variance weighted,25,0.97 [0.87-1.09],0.623930962509686,trans
Chapter IX Diseases of the circulatory system,I9_AF,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,0.85 [0.44-1.64],0.624987255536198,trans
Chapter IX Diseases of the circulatory system,I9_AF,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,Inverse variance weighted,17,0.99 [0.94-1.04],0.62709961918807,trans
Chapter IX Diseases of the circulatory system,I9_AF,CA9,Carbonic anhydrase 9,Inverse variance weighted,8,1.06 [0.83-1.37],0.627685597953284,trans
Chapter IX Diseases of the circulatory system,I9_AF,PGF,Placenta growth factor,Inverse variance weighted,5,1.09 [0.78-1.52],0.627728484340311,trans
Chapter IX Diseases of the circulatory system,I9_AF,MYOM3,Myomesin-3,Inverse variance weighted,24,0.97 [0.84-1.11],0.62855260584301,trans
Chapter IX Diseases of the circulatory system,I9_AF,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.06 [0.83-1.35],0.634211410597627,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPON1,Spondin-1,Inverse variance weighted,4,1.07 [0.81-1.42],0.634372561604762,trans
Chapter IX Diseases of the circulatory system,I9_AF,SIGLEC7,Sialic acid-binding Ig-like lectin 7,Inverse variance weighted,6,0.97 [0.83-1.12],0.636553407136846,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD34,Hematopoietic progenitor cell antigen CD34,Inverse variance weighted,2,0.89 [0.54-1.46],0.6385249532316,trans
Chapter IX Diseases of the circulatory system,I9_AF,DKK3,Dickkopf-related protein 3,Inverse variance weighted,14,1.03 [0.92-1.14],0.642561814954905,trans
Chapter IX Diseases of the circulatory system,I9_AF,FCN2,Ficolin-2,Inverse variance weighted,53,1.01 [0.97-1.04],0.642794041964669,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL12B,Interleukin-12 subunit beta,Inverse variance weighted,39,0.99 [0.93-1.05],0.644962870663255,trans
Chapter IX Diseases of the circulatory system,I9_AF,TG,Thyroglobulin,Inverse variance weighted,36,1.02 [0.94-1.11],0.645675332074186,trans
Chapter IX Diseases of the circulatory system,I9_AF,IMMT,MICOS complex subunit MIC60,Wald ratio,1,0.93 [0.66-1.29],0.647311888735948,trans
Chapter IX Diseases of the circulatory system,I9_AF,TSPAN8,Tetraspanin-8,Inverse variance weighted,19,1.02 [0.93-1.13],0.649084393707509,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL3A1,Collagen alpha-1(III) chain,Inverse variance weighted,5,0.98 [0.88-1.08],0.649521699382764,trans
Chapter IX Diseases of the circulatory system,I9_AF,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,Inverse variance weighted,11,0.99 [0.95-1.04],0.651867318455539,trans
Chapter IX Diseases of the circulatory system,I9_AF,ANG,Angiogenin,Inverse variance weighted,9,1.06 [0.82-1.37],0.6588294636514,trans
Chapter IX Diseases of the circulatory system,I9_AF,MMP3,Stromelysin-1,Inverse variance weighted,4,1.06 [0.82-1.37],0.660231449793249,trans
Chapter IX Diseases of the circulatory system,I9_AF,CYTL1,Cytokine-like protein 1,Inverse variance weighted,3,0.87 [0.47-1.62],0.661858031269362,trans
Chapter IX Diseases of the circulatory system,I9_AF,GPR15L,Protein GPR15L,Inverse variance weighted,13,0.99 [0.93-1.05],0.663204543041812,trans
Chapter IX Diseases of the circulatory system,I9_AF,PCDHB15,Protocadherin beta-15,Inverse variance weighted,19,1.02 [0.93-1.11],0.66496625123924,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXCL17,C-X-C motif chemokine 17,Inverse variance weighted,6,1.07 [0.79-1.45],0.666410830190899,trans
Chapter IX Diseases of the circulatory system,I9_AF,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,1.05 [0.85-1.28],0.66747500464623,trans
Chapter IX Diseases of the circulatory system,I9_AF,THY1,Thy-1 membrane glycoprotein,Wald ratio,1,1.11 [0.68-1.81],0.667528528252722,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.99 [0.96-1.03],0.671810986109676,trans
Chapter IX Diseases of the circulatory system,I9_AF,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,Inverse variance weighted,11,1.06 [0.81-1.38],0.673342435323092,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.03 [0.89-1.2],0.674310970197296,trans
Chapter IX Diseases of the circulatory system,I9_AF,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",Inverse variance weighted,3,0.96 [0.81-1.15],0.674668450005421,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADGRD1,Adhesion G-protein coupled receptor D1,Inverse variance weighted,15,1.04 [0.86-1.27],0.675177146122367,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,1.08 [0.74-1.58],0.675635527367147,trans
Chapter IX Diseases of the circulatory system,I9_AF,MFAP4,Microfibril-associated glycoprotein 4,Inverse variance weighted,15,0.98 [0.87-1.09],0.681663163132959,trans
Chapter IX Diseases of the circulatory system,I9_AF,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Inverse variance weighted,16,1.05 [0.84-1.3],0.682459512135884,trans
Chapter IX Diseases of the circulatory system,I9_AF,LEFTY2,Left-right determination factor 2,Inverse variance weighted,7,1.06 [0.8-1.39],0.682958134960466,trans
Chapter IX Diseases of the circulatory system,I9_AF,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,0.95 [0.73-1.23],0.683252625407804,trans
Chapter IX Diseases of the circulatory system,I9_AF,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.98 [0.89-1.08],0.685118855691207,trans
Chapter IX Diseases of the circulatory system,I9_AF,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.95 [0.72-1.24],0.685250509565491,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,Inverse variance weighted,25,0.98 [0.86-1.1],0.686278399868191,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,0.96 [0.78-1.17],0.687287125341352,trans
Chapter IX Diseases of the circulatory system,I9_AF,BCAN,Brevican core protein,Inverse variance weighted,12,1.03 [0.89-1.19],0.6877503897271,trans
Chapter IX Diseases of the circulatory system,I9_AF,KCTD5,BTB/POZ domain-containing protein KCTD5,Inverse variance weighted,5,1.06 [0.8-1.41],0.688414622531719,trans
Chapter IX Diseases of the circulatory system,I9_AF,EPO,Erythropoietin,Inverse variance weighted,11,1.02 [0.93-1.11],0.689440087091077,trans
Chapter IX Diseases of the circulatory system,I9_AF,GRPEL1,"GrpE protein homolog 1, mitochondrial",Inverse variance weighted,2,0.93 [0.65-1.33],0.689535855735461,trans
Chapter IX Diseases of the circulatory system,I9_AF,EGFL7,Epidermal growth factor-like protein 7,Inverse variance weighted,29,1.01 [0.95-1.08],0.690461363080903,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.01 [0.98-1.03],0.691674898068274,trans
Chapter IX Diseases of the circulatory system,I9_AF,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.96 [0.8-1.16],0.691706706061109,trans
Chapter IX Diseases of the circulatory system,I9_AF,PGA4,Pepsin A-4,Inverse variance weighted,7,0.95 [0.75-1.21],0.69201704500626,trans
Chapter IX Diseases of the circulatory system,I9_AF,STC1,Stanniocalcin-1,Inverse variance weighted,9,1.02 [0.91-1.14],0.693090330501246,trans
Chapter IX Diseases of the circulatory system,I9_AF,HNMT,Histamine N-methyltransferase,Inverse variance weighted,10,1.02 [0.92-1.14],0.693582370885586,trans
Chapter IX Diseases of the circulatory system,I9_AF,WIF1,Wnt inhibitory factor 1,Inverse variance weighted,31,1.01 [0.94-1.09],0.699520600550711,trans
Chapter IX Diseases of the circulatory system,I9_AF,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,1.04 [0.84-1.29],0.700319105128558,trans
Chapter IX Diseases of the circulatory system,I9_AF,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.98 [0.89-1.09],0.703452736098664,trans
Chapter IX Diseases of the circulatory system,I9_AF,AGXT,Serine--pyruvate aminotransferase,Inverse variance weighted,12,0.98 [0.89-1.08],0.703732426664123,trans
Chapter IX Diseases of the circulatory system,I9_AF,CA5A,"Carbonic anhydrase 5A, mitochondrial",Inverse variance weighted,4,1.05 [0.83-1.31],0.706272313030216,trans
Chapter IX Diseases of the circulatory system,I9_AF,FABP2,"Fatty acid-binding protein, intestinal",Inverse variance weighted,6,1.05 [0.83-1.32],0.707022700680283,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD83,CD83 antigen,Inverse variance weighted,14,1.02 [0.9-1.16],0.707834605502596,trans
Chapter IX Diseases of the circulatory system,I9_AF,NHLRC3,NHL repeat-containing protein 3,Inverse variance weighted,5,1.04 [0.86-1.25],0.709865111365579,trans
Chapter IX Diseases of the circulatory system,I9_AF,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.05 [0.79-1.4],0.713776235030256,trans
Chapter IX Diseases of the circulatory system,I9_AF,BPIFB2,BPI fold-containing family B member 2,Inverse variance weighted,37,1.01 [0.95-1.07],0.714338988321375,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLK8,Kallikrein-8,Inverse variance weighted,5,0.95 [0.7-1.28],0.717624727518521,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,0.98 [0.87-1.1],0.718788544604979,trans
Chapter IX Diseases of the circulatory system,I9_AF,DNER,Delta and Notch-like epidermal growth factor-related receptor,Inverse variance weighted,18,1.02 [0.93-1.11],0.721922897695445,trans
Chapter IX Diseases of the circulatory system,I9_AF,OLR1,Oxidized low-density lipoprotein receptor 1,Inverse variance weighted,17,1.03 [0.89-1.19],0.724907661175969,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLPS,Colipase,Inverse variance weighted,28,0.99 [0.91-1.07],0.72505386785263,trans
Chapter IX Diseases of the circulatory system,I9_AF,CNTN5,Contactin-5,Inverse variance weighted,22,0.99 [0.91-1.07],0.726237729956176,trans
Chapter IX Diseases of the circulatory system,I9_AF,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,Inverse variance weighted,9,1.02 [0.89-1.18],0.731279465963193,trans
Chapter IX Diseases of the circulatory system,I9_AF,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.95 [0.72-1.25],0.731658264953974,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,1.02 [0.89-1.17],0.733858520148531,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL16,C-C motif chemokine 16,Inverse variance weighted,26,0.99 [0.97-1.02],0.734338206600704,trans
Chapter IX Diseases of the circulatory system,I9_AF,PALM,Paralemmin-1,Inverse variance weighted,4,1.05 [0.8-1.37],0.737352801204131,trans
Chapter IX Diseases of the circulatory system,I9_AF,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",Inverse variance weighted,18,1.02 [0.92-1.13],0.738714421606034,trans
Chapter IX Diseases of the circulatory system,I9_AF,RNASE6,Ribonuclease K6,Inverse variance weighted,4,1.04 [0.81-1.34],0.744504060029878,trans
Chapter IX Diseases of the circulatory system,I9_AF,SLITRK2,SLIT and NTRK-like protein 2,Inverse variance weighted,12,0.98 [0.86-1.12],0.748411298165002,trans
Chapter IX Diseases of the circulatory system,I9_AF,ROBO1,Roundabout homolog 1,Inverse variance weighted,18,0.98 [0.85-1.12],0.75105823183233,trans
Chapter IX Diseases of the circulatory system,I9_AF,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.01 [0.94-1.08],0.756875169561752,trans
Chapter IX Diseases of the circulatory system,I9_AF,LAG3,Lymphocyte activation gene 3 protein,Inverse variance weighted,11,1.03 [0.85-1.25],0.757169602730848,trans
Chapter IX Diseases of the circulatory system,I9_AF,ITGAM,Integrin alpha-M,Inverse variance weighted,12,0.98 [0.89-1.09],0.758031388780865,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGFBP1,Fibroblast growth factor-binding protein 1,Inverse variance weighted,12,1.03 [0.83-1.29],0.758480199928411,trans
Chapter IX Diseases of the circulatory system,I9_AF,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,1.04 [0.8-1.36],0.758932114937496,trans
Chapter IX Diseases of the circulatory system,I9_AF,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,Inverse variance weighted,3,0.94 [0.63-1.4],0.75893709280829,trans
Chapter IX Diseases of the circulatory system,I9_AF,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.97 [0.77-1.21],0.760105126742348,trans
Chapter IX Diseases of the circulatory system,I9_AF,LAMB1,Laminin subunit beta-1,Inverse variance weighted,21,1.01 [0.94-1.1],0.761496094121959,trans
Chapter IX Diseases of the circulatory system,I9_AF,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,1.04 [0.79-1.37],0.761864568237194,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLK11,Kallikrein-11,Inverse variance weighted,13,1.02 [0.91-1.13],0.763548051495231,trans
Chapter IX Diseases of the circulatory system,I9_AF,MVK,Mevalonate kinase,Wald ratio,1,1.16 [0.44-3.02],0.764433097425744,trans
Chapter IX Diseases of the circulatory system,I9_AF,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.93 [0.58-1.5],0.765816054389221,trans
Chapter IX Diseases of the circulatory system,I9_AF,WARS,"Tryptophan--tRNA ligase, cytoplasmic",Wald ratio,1,1.07 [0.67-1.72],0.766638226758014,trans
Chapter IX Diseases of the circulatory system,I9_AF,AGRN,Agrin,Inverse variance weighted,14,0.97 [0.82-1.16],0.766945415025451,trans
Chapter IX Diseases of the circulatory system,I9_AF,NCAN,Neurocan core protein,Inverse variance weighted,19,0.99 [0.91-1.07],0.77010387773106,trans
Chapter IX Diseases of the circulatory system,I9_AF,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,0.98 [0.88-1.1],0.771816613742728,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.02 [0.91-1.14],0.773351185325737,trans
Chapter IX Diseases of the circulatory system,I9_AF,CFD,Complement factor D,Wald ratio,1,1.06 [0.71-1.6],0.774508425668943,trans
Chapter IX Diseases of the circulatory system,I9_AF,CTSD,Cathepsin D,Inverse variance weighted,7,0.97 [0.8-1.18],0.775189749915436,trans
Chapter IX Diseases of the circulatory system,I9_AF,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,Inverse variance weighted,11,1.02 [0.89-1.16],0.777595073304073,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,0.98 [0.87-1.11],0.78050037846338,trans
Chapter IX Diseases of the circulatory system,I9_AF,RBP5,Retinol-binding protein 5,Inverse variance weighted,2,0.96 [0.73-1.26],0.782218065859047,trans
Chapter IX Diseases of the circulatory system,I9_AF,NPL,N-acetylneuraminate lyase,Inverse variance weighted,5,1.02 [0.88-1.18],0.782868684080412,trans
Chapter IX Diseases of the circulatory system,I9_AF,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.96 [0.7-1.31],0.783540307401725,trans
Chapter IX Diseases of the circulatory system,I9_AF,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,1.02 [0.89-1.16],0.783589475918914,trans
Chapter IX Diseases of the circulatory system,I9_AF,TTR,Transthyretin,Inverse variance weighted,11,0.98 [0.87-1.11],0.785487245463648,trans
Chapter IX Diseases of the circulatory system,I9_AF,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,1.06 [0.68-1.65],0.786383367060097,trans
Chapter IX Diseases of the circulatory system,I9_AF,POF1B,Protein POF1B,Inverse variance weighted,4,0.98 [0.82-1.16],0.786387666370535,trans
Chapter IX Diseases of the circulatory system,I9_AF,EGFLAM,Pikachurin,Wald ratio,1,1.09 [0.58-2.05],0.791693334782009,trans
Chapter IX Diseases of the circulatory system,I9_AF,AMBP,Protein AMBP,Inverse variance weighted,5,1.04 [0.78-1.39],0.794360853037915,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXCL3,C-X-C motif chemokine 3,Wald ratio,1,1.05 [0.73-1.51],0.79663813083219,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,Inverse variance weighted,4,1.07 [0.64-1.8],0.796753448413195,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,1.02 [0.87-1.21],0.797483435153594,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD27,CD27 antigen,Inverse variance weighted,9,0.96 [0.72-1.29],0.803926407182394,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,1.02 [0.89-1.16],0.806601866833011,trans
Chapter IX Diseases of the circulatory system,I9_AF,SERPIND1,Heparin cofactor 2,Inverse variance weighted,32,1.02 [0.9-1.15],0.806842132274305,trans
Chapter IX Diseases of the circulatory system,I9_AF,CA6,Carbonic anhydrase 6,Inverse variance weighted,20,0.99 [0.88-1.1],0.808068225478838,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGSF3,Immunoglobulin superfamily member 3,Inverse variance weighted,4,1.03 [0.78-1.36],0.818686749503194,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,1.04 [0.75-1.43],0.819186244469648,trans
Chapter IX Diseases of the circulatory system,I9_AF,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.99 [0.95-1.04],0.81942350958074,trans
Chapter IX Diseases of the circulatory system,I9_AF,COLEC12,Collectin-12,Inverse variance weighted,3,0.97 [0.72-1.29],0.819550656743203,trans
Chapter IX Diseases of the circulatory system,I9_AF,BSG,Basigin,Inverse variance weighted,6,1.03 [0.82-1.29],0.82047428461954,trans
Chapter IX Diseases of the circulatory system,I9_AF,RAB6A,Ras-related protein Rab-6A,Inverse variance weighted,27,1.01 [0.96-1.06],0.820922730353364,trans
Chapter IX Diseases of the circulatory system,I9_AF,PXN,Paxillin,Inverse variance weighted,7,1.02 [0.88-1.17],0.823179017399414,trans
Chapter IX Diseases of the circulatory system,I9_AF,CLEC4D,C-type lectin domain family 4 member D,Inverse variance weighted,9,0.98 [0.86-1.13],0.823219473478201,trans
Chapter IX Diseases of the circulatory system,I9_AF,VCAN,Versican core protein,Inverse variance weighted,30,0.99 [0.93-1.06],0.823606763184679,trans
Chapter IX Diseases of the circulatory system,I9_AF,CHGB,Secretogranin-1,Inverse variance weighted,7,1.04 [0.76-1.41],0.825628584669217,trans
Chapter IX Diseases of the circulatory system,I9_AF,KLK14,Kallikrein-14,Inverse variance weighted,15,1.02 [0.88-1.18],0.826777658510725,trans
Chapter IX Diseases of the circulatory system,I9_AF,SULT2A1,Bile salt sulfotransferase,Inverse variance weighted,3,0.98 [0.78-1.22],0.832820869653479,trans
Chapter IX Diseases of the circulatory system,I9_AF,CNTNAP2,Contactin-associated protein-like 2,Inverse variance weighted,11,1.01 [0.9-1.14],0.833274753698746,trans
Chapter IX Diseases of the circulatory system,I9_AF,SFTPD,Pulmonary surfactant-associated protein D,Inverse variance weighted,54,1 [0.97-1.04],0.833949987309318,trans
Chapter IX Diseases of the circulatory system,I9_AF,UMOD,Uromodulin,Inverse variance weighted,34,1.01 [0.92-1.11],0.839058661561679,trans
Chapter IX Diseases of the circulatory system,I9_AF,TFF2,Trefoil factor 2,Inverse variance weighted,16,1.01 [0.9-1.13],0.839325958652894,trans
Chapter IX Diseases of the circulatory system,I9_AF,CHGA,Chromogranin-A,Inverse variance weighted,5,1.02 [0.84-1.25],0.839580680978206,trans
Chapter IX Diseases of the circulatory system,I9_AF,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.98 [0.83-1.16],0.840281985825543,trans
Chapter IX Diseases of the circulatory system,I9_AF,LGMN,Legumain,Inverse variance weighted,22,1.01 [0.89-1.16],0.841631782844211,trans
Chapter IX Diseases of the circulatory system,I9_AF,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.03 [0.74-1.44],0.84249600514038,trans
Chapter IX Diseases of the circulatory system,I9_AF,FCN1,Ficolin-1,Inverse variance weighted,50,1 [0.96-1.04],0.843455714863546,trans
Chapter IX Diseases of the circulatory system,I9_AF,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,Inverse variance weighted,7,0.98 [0.77-1.25],0.847100190427637,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,1.01 [0.89-1.16],0.848339166507749,trans
Chapter IX Diseases of the circulatory system,I9_AF,QSOX1,Sulfhydryl oxidase 1,Inverse variance weighted,7,0.99 [0.9-1.09],0.848506678063413,trans
Chapter IX Diseases of the circulatory system,I9_AF,ERMAP,Erythroid membrane-associated protein,Inverse variance weighted,33,1 [0.97-1.04],0.850782944531909,trans
Chapter IX Diseases of the circulatory system,I9_AF,LAMP3,Lysosome-associated membrane glycoprotein 3,Inverse variance weighted,13,1.02 [0.82-1.27],0.850899592981789,trans
Chapter IX Diseases of the circulatory system,I9_AF,FABP6,Gastrotropin,Inverse variance weighted,4,1.02 [0.81-1.28],0.851929635732504,trans
Chapter IX Diseases of the circulatory system,I9_AF,CNDP1,Beta-Ala-His dipeptidase,Inverse variance weighted,48,1 [0.96-1.03],0.852802005557519,trans
Chapter IX Diseases of the circulatory system,I9_AF,LRG1,Leucine-rich alpha-2-glycoprotein,Inverse variance weighted,4,0.95 [0.52-1.73],0.856479993503946,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.99 [0.91-1.08],0.857031054600816,trans
Chapter IX Diseases of the circulatory system,I9_AF,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,Wald ratio,1,0.96 [0.62-1.48],0.858054594202641,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,0.99 [0.91-1.08],0.858123548854987,trans
Chapter IX Diseases of the circulatory system,I9_AF,S100A4,Protein S100-A4,Inverse variance weighted,2,0.97 [0.71-1.32],0.859139021820532,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNFSF10,Tumor necrosis factor ligand superfamily member 10,Inverse variance weighted,20,1.01 [0.87-1.18],0.862580156492586,trans
Chapter IX Diseases of the circulatory system,I9_AF,ITGA11,Integrin alpha-11,Inverse variance weighted,7,1.02 [0.79-1.33],0.865411061605748,trans
Chapter IX Diseases of the circulatory system,I9_AF,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.99 [0.84-1.15],0.867458072199409,trans
Chapter IX Diseases of the circulatory system,I9_AF,CAPG,Macrophage-capping protein,Wald ratio,1,0.97 [0.68-1.39],0.868040983138866,trans
Chapter IX Diseases of the circulatory system,I9_AF,SERPINA11,Serpin A11,Inverse variance weighted,14,0.98 [0.8-1.21],0.869957082926053,trans
Chapter IX Diseases of the circulatory system,I9_AF,PVR,Poliovirus receptor,Inverse variance weighted,3,0.98 [0.75-1.28],0.870763792334568,trans
Chapter IX Diseases of the circulatory system,I9_AF,PLXDC2,Plexin domain-containing protein 2,Inverse variance weighted,8,0.99 [0.9-1.09],0.871158512483863,trans
Chapter IX Diseases of the circulatory system,I9_AF,IFNG,Interferon gamma,Inverse variance weighted,5,1.02 [0.82-1.26],0.872160655632146,trans
Chapter IX Diseases of the circulatory system,I9_AF,TYRO3,Tyrosine-protein kinase receptor TYRO3,Inverse variance weighted,20,0.99 [0.86-1.13],0.87277107387069,trans
Chapter IX Diseases of the circulatory system,I9_AF,GDNF,Glial cell line-derived neurotrophic factor,Inverse variance weighted,5,0.98 [0.78-1.24],0.87389151896796,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.99 [0.89-1.11],0.876615900473523,trans
Chapter IX Diseases of the circulatory system,I9_AF,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.06 [0.52-2.15],0.878636872318601,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,0.99 [0.88-1.11],0.880268128513003,trans
Chapter IX Diseases of the circulatory system,I9_AF,SPINT2,Kunitz-type protease inhibitor 2,Inverse variance weighted,7,0.99 [0.89-1.11],0.880671151187953,trans
Chapter IX Diseases of the circulatory system,I9_AF,CXCL10,C-X-C motif chemokine 10,Inverse variance weighted,6,1.03 [0.74-1.43],0.881600647944535,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,0.98 [0.7-1.36],0.883465986629357,trans
Chapter IX Diseases of the circulatory system,I9_AF,ELN,Elastin,Inverse variance weighted,10,1.01 [0.86-1.19],0.886179200778404,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRG2,Bone marrow proteoglycan,Inverse variance weighted,39,1 [0.94-1.05],0.887693649568723,trans
Chapter IX Diseases of the circulatory system,I9_AF,FOLR1,Folate receptor alpha,Inverse variance weighted,6,1.02 [0.8-1.29],0.888161475303126,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGF21,Fibroblast growth factor 21,Inverse variance weighted,2,1.02 [0.76-1.37],0.889780635695273,trans
Chapter IX Diseases of the circulatory system,I9_AF,FRZB,Secreted frizzled-related protein 3,Inverse variance weighted,14,0.99 [0.92-1.07],0.890478054511902,trans
Chapter IX Diseases of the circulatory system,I9_AF,CFP,Properdin,Inverse variance weighted,17,1 [0.94-1.08],0.892035028587158,trans
Chapter IX Diseases of the circulatory system,I9_AF,NPPC,C-type natriuretic peptide,Inverse variance weighted,3,0.96 [0.49-1.85],0.892148842536432,trans
Chapter IX Diseases of the circulatory system,I9_AF,PRELP,Prolargin,Inverse variance weighted,5,0.98 [0.72-1.34],0.893908418672078,trans
Chapter IX Diseases of the circulatory system,I9_AF,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,0.99 [0.88-1.12],0.896297388907245,trans
Chapter IX Diseases of the circulatory system,I9_AF,RSPO3,R-spondin-3,Inverse variance weighted,5,0.98 [0.72-1.34],0.898258019060734,trans
Chapter IX Diseases of the circulatory system,I9_AF,SCG2,Secretogranin-2,Inverse variance weighted,2,1.02 [0.8-1.3],0.899786006862452,trans
Chapter IX Diseases of the circulatory system,I9_AF,TNC,Tenascin,Inverse variance weighted,57,1 [0.96-1.04],0.90066749546918,trans
Chapter IX Diseases of the circulatory system,I9_AF,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.01 [0.87-1.17],0.901155758906642,trans
Chapter IX Diseases of the circulatory system,I9_AF,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1 [0.92-1.08],0.904703736321865,trans
Chapter IX Diseases of the circulatory system,I9_AF,CHRDL2,Chordin-like protein 2,Inverse variance weighted,9,1.01 [0.88-1.16],0.908000266014711,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL6ST,Interleukin-6 receptor subunit beta,Inverse variance weighted,7,1.01 [0.8-1.29],0.91035962062621,trans
Chapter IX Diseases of the circulatory system,I9_AF,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,1.02 [0.77-1.34],0.912270397245042,trans
Chapter IX Diseases of the circulatory system,I9_AF,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,1 [0.91-1.08],0.914391056809035,trans
Chapter IX Diseases of the circulatory system,I9_AF,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.03 [0.64-1.65],0.916333778029952,trans
Chapter IX Diseases of the circulatory system,I9_AF,MMP10,Stromelysin-2,Wald ratio,1,0.97 [0.6-1.59],0.917494240756448,trans
Chapter IX Diseases of the circulatory system,I9_AF,CCL25,C-C motif chemokine 25,Inverse variance weighted,22,1 [0.94-1.07],0.920766677368998,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,Inverse variance weighted,24,1 [0.93-1.08],0.921393893203969,trans
Chapter IX Diseases of the circulatory system,I9_AF,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,0.99 [0.86-1.15],0.921828035100561,trans
Chapter IX Diseases of the circulatory system,I9_AF,ROBO2,Roundabout homolog 2,Inverse variance weighted,6,1.01 [0.88-1.15],0.922182966524476,trans
Chapter IX Diseases of the circulatory system,I9_AF,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1 [0.92-1.08],0.924205464848809,trans
Chapter IX Diseases of the circulatory system,I9_AF,SELENOP,Selenoprotein P,Inverse variance weighted,3,1.02 [0.71-1.45],0.92442315382796,trans
Chapter IX Diseases of the circulatory system,I9_AF,MMP9,Matrix metalloproteinase-9,Inverse variance weighted,11,1 [0.92-1.09],0.92738869891177,trans
Chapter IX Diseases of the circulatory system,I9_AF,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,1.01 [0.84-1.21],0.929028934685876,trans
Chapter IX Diseases of the circulatory system,I9_AF,WNT9A,Protein Wnt-9a,Wald ratio,1,0.98 [0.57-1.68],0.92910972486735,trans
Chapter IX Diseases of the circulatory system,I9_AF,SEMA7A,Semaphorin-7A,Inverse variance weighted,20,1 [0.9-1.1],0.932135523653057,trans
Chapter IX Diseases of the circulatory system,I9_AF,SERPINA5,Plasma serine protease inhibitor,Inverse variance weighted,7,1.01 [0.87-1.16],0.933685069216767,trans
Chapter IX Diseases of the circulatory system,I9_AF,AMIGO2,Amphoterin-induced protein 2,Inverse variance weighted,15,1.01 [0.86-1.17],0.93534627152093,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD28,T-cell-specific surface glycoprotein CD28,Inverse variance weighted,11,1 [0.87-1.13],0.940222570481393,trans
Chapter IX Diseases of the circulatory system,I9_AF,SRPX,Sushi repeat-containing protein SRPX,Inverse variance weighted,2,1.02 [0.53-1.97],0.942413518286703,trans
Chapter IX Diseases of the circulatory system,I9_AF,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,1.01 [0.76-1.35],0.943014244438788,trans
Chapter IX Diseases of the circulatory system,I9_AF,PKD1,Polycystin-1,Inverse variance weighted,12,0.99 [0.82-1.2],0.943468447851287,trans
Chapter IX Diseases of the circulatory system,I9_AF,ADIPOQ,Adiponectin,Inverse variance weighted,25,1 [0.91-1.11],0.948538949399545,trans
Chapter IX Diseases of the circulatory system,I9_AF,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.01 [0.84-1.21],0.955710704687145,trans
Chapter IX Diseases of the circulatory system,I9_AF,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,1.01 [0.8-1.26],0.957006533684937,trans
Chapter IX Diseases of the circulatory system,I9_AF,SERPINB8,Serpin B8,Inverse variance weighted,29,1 [0.98-1.02],0.957621648947023,trans
Chapter IX Diseases of the circulatory system,I9_AF,CDH6,Cadherin-6,Inverse variance weighted,5,1.01 [0.77-1.32],0.961700748170913,trans
Chapter IX Diseases of the circulatory system,I9_AF,FCAR,Immunoglobulin alpha Fc receptor,Inverse variance weighted,15,1 [0.83-1.21],0.962431063794252,trans
Chapter IX Diseases of the circulatory system,I9_AF,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.01 [0.72-1.4],0.966585486577326,trans
Chapter IX Diseases of the circulatory system,I9_AF,LTBP3,Latent-transforming growth factor beta-binding protein 3,Inverse variance weighted,16,1 [0.93-1.08],0.966779167020143,trans
Chapter IX Diseases of the circulatory system,I9_AF,CALB1,Calbindin,Inverse variance weighted,9,1 [0.89-1.12],0.968096557165362,trans
Chapter IX Diseases of the circulatory system,I9_AF,EFHD1,EF-hand domain-containing protein D1,Inverse variance weighted,4,1 [0.87-1.14],0.969654299171182,trans
Chapter IX Diseases of the circulatory system,I9_AF,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1 [0.91-1.11],0.970955299509723,trans
Chapter IX Diseases of the circulatory system,I9_AF,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",Inverse variance weighted,22,1 [0.96-1.04],0.975643604267735,trans
Chapter IX Diseases of the circulatory system,I9_AF,TFF3,Trefoil factor 3,Inverse variance weighted,10,1 [0.82-1.21],0.977392113699097,trans
Chapter IX Diseases of the circulatory system,I9_AF,CTSL,Cathepsin L1,Inverse variance weighted,29,1 [0.91-1.1],0.978793023769403,trans
Chapter IX Diseases of the circulatory system,I9_AF,F3,Tissue factor,Inverse variance weighted,13,1 [0.87-1.15],0.983315920743676,trans
Chapter IX Diseases of the circulatory system,I9_AF,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,1 [0.73-1.37],0.98800845807458,trans
Chapter IX Diseases of the circulatory system,I9_AF,MB,Myoglobin,Inverse variance weighted,9,1 [0.78-1.28],0.988292544561269,trans
Chapter IX Diseases of the circulatory system,I9_AF,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1 [0.92-1.08],0.989544514796574,trans
Chapter IX Diseases of the circulatory system,I9_AF,SOD2,"Superoxide dismutase [Mn], mitochondrial",Inverse variance weighted,7,1 [0.54-1.83],0.991683279708759,trans
Chapter IX Diseases of the circulatory system,I9_AF,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1 [0.75-1.34],0.996466985191671,trans
Chapter IX Diseases of the circulatory system,I9_AF,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1 [0.81-1.23],0.998211332397172,trans
